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Unintentional overdose of over-the-counter (OTC) medications has become an increasing
global public health concern due to the common and frequent use of painkillers among end
users, to self-medicate and medicate others, without fully understanding the associated
health risks. While many developed countries have started to implement measures in an
attempt to reduce access to large quantities and raise awareness of the dangers of misuse
of OTC medications, this is not the case in many middle and low income countries. Instead,
many individuals are forced to rely on written information while faced with poor health
literacy, inadequate information and limited verbal information from health professionals,
all of which contribute to the increase in unsafe behaviours leading to overdosing.
In South Africa, most unintentional overdoses from OTC painkillers occur in children, which
can often be attributed to incorrect dosing from caregivers. With the common practice of
re-packaging medications at a distribution level, individuals are often not provided with
adequate information about their medication, appropriate for their level of health literacy.
This study explored whether caregivers are able to make informed decisions about the
correct and safe administration of popular OTC painkillers (specifically paracetamol) to their
children, based on information from labels, medication inserts and/or patient information
leaflets (PILs). 
The protocol (part A) provides a justification for the study and describes the methods used 
to collect and analyse the data. The literature review (part B) describes the extent of OTC 
medication overdose globally as well as the current regulations in South Africa around OTC 











decision making when using OTC medication are also discussed. The article (part C) presents 
research findings on whether caregivers in South Africa were able to make informed 
decisions about dosing, risk and use of paracetamol, specifically through the access to and 
comprehension of labels, medication inserts and/or PILs. The study found that caregivers do 
not have access to enough information to make informed decisions about administering 
medication to their children. Those who are provided with sufficient information are usually 
the end users who are already educated and have adequate levels of health literacy to make 
informed decisions with the information provided. Pictograms, clearer formatting and use of 
clear lay language appropriate for the health literacy of end users were found to be 
imperative for encouraging caregivers to make informed decisions about dosage and risks 
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Unintentional overdose of over-the-counter (OTC) medications has become an increasing 
global Public Health concern. While many developed countries have started to implement 
measures in an attempt to reduce access to large quantities and raise awareness of the 
dangers of misuse of OTC medications, this is not the case in many developing countries. 
Instead, many individuals are faced with poor health literacy, inadequate information and 
the ability to purchase large quantities of medication without much knowledge of the 
associated risks. 
 
In South Africa, most unintentional overdoses from OTC painkillers occur in children, which 
can often be attributed to incorrect dosing from caregivers. With the common practice of 
re-packaging medications at a distribution level, individuals are often not provided with 
adequate information about their medication, which is against their constitutional right to 
information, and could have significant consequences for their health. The purpose of this 
research study is to determine whether caregivers are provided with adequate dosing and 
risk information about popular over-the-counter medications, thereby allowing them to 
make informed and risk reduction decisions about their own health as well as the health of 
their families. This will be done through the administration of a questionnaire to caregivers 
and pharmaceutical service providers in Cape Town, South Africa across socioeconomic 
groups. Recommendations as to how to improve health risk communication for OTC 














1. Justification  
1.1 Introduction 
The South African Patients’ Rights Charter states that everyone has the right to access to 
healthcare in the form of health information (1). The World Health Organisation 
recommends that all essential medicines be available with assured quality and adequate 
information and the South African National Department of Health aims to ensure that all 
citizens have access to medicines, which are available and accessible for all people (2). The 
South African government also acknowledges that a crucial and often deficient element in 
curative services is the adequate supply and dispensing of appropriate medicines (2). The 
main objectives of the National Drug Policy are: 
• To ensure the availability and accessibility of essential medicines to all citizens. 
• To ensure the safety, efficacy and quality of drugs.  
• To ensure good prescribing and dispensing practices. 
• To promote the rational use of drugs by prescribers, dispensers and patients through 
provision of the necessary training, education and information. 
• To promote the concept of individual responsibility for health, preventive care and 
informed decision-making (2). 
 
It is clear from the last objective of the National Drug Policy that the South African 
government aims to promote three specific concepts, specifically the concept of individuals 
being able to take responsibility for their own health, individuals being able to make use of, 
and practice preventive care and individuals being equipped to make informed decision-












access to medication, one needs to determine whether these three concepts are being 
upheld in the South African context. Other than the state’s responsibility to uphold the 
rights of its citizens, it is imperative that individuals are equipped to make informed 
decisions about their health to prevent or reduce the life threatening risks associated with 
incorrect use of medication such as co-morbid conditions or in some cases, death. 
Therefore, if the abovementioned concepts are not upheld, the barriers need to be 
identified. This research aims to determine whether caregivers are able to exercise their 
right to access to health information in order to make informed decisions about their and 
their families’ use of popular OTC painkillers specifically, through the access to and use of 
medication inserts and/or patient education leaflets.  
 
1.2. Access to medication information 
In South Africa, there are three major means of communicating necessary medication 
information to end-users, (i.e. indications, contraindications, side effects, dosage, directions 
for use, warnings, etc). According to legislation, “all medicine intended for administration to 
humans shall have a label attached to it, with each package accompanied by a medication 
insert and Patient Information Leaflet (PIL) (3). Certain regulations regarding the 
standardisation of information are not clear and those that are available are not always 
implemented, with some medications being provided with only one or two means of 
communication, or in some cases, with no additional information. The written information 
provided with medication does not incorporate any Braille or other assistive technology, 















The way in which medicines are dispensed in South Africa, varies from facility to facility. 
Certain brands of OTC medication (e.g. Panado™), will be sold in a box which contains a 
certain amount of tablets per box. In some public facilities and private pharmacies, 
medication is often dispensed into small packets (see Figure 1) or containers (usually 
generics). These boxes, packets and containers will usually have some form of label on them 
providing specific information, however information can be limited to the name of the 
medication and/ or its generic dosage. The legislation clearly states that the container of 
every medicine intended for human use must have a label clearly attached to it in English 
and one other official language (3). The container label should provide basic information 
about the medication such as the medication’s name, patient’s name, dosage, instructions 
indications, special instructions and general warnings and is created by the manufacturer of 
the medication (3). In certain South African settings it is not always possible to have a 
medication insert accompanying the medication, making the label incredibly important, as it 
is the consumer’s only means of access to information.  
 
Studies in the United States have found that readability of labels can be increased by having 
larger font, boldfacing, use of white space and aesthetically pleasing designs (4). However, 
the Act 101 does not have clear guidelines stipulating the font size or other instructions 
pertaining to the design of the label, allowing for a variety of labels being produced in South 
Africa (3). A study conducted in the United States found that those with low literacy were 
three times more likely to misinterpret warnings on labels than those with higher literacy 
levels, with some participants misinterpreting seven out of eight warnings on the label (5). 












risks associated with the substance being sold and has found pictograms to be particularly 
effective in attracting attention, reminding consumers of safety messages already known 
and aiding in conveying messages that are difficult to describe in text, especially for those 
who have limited health literacy (6). A study conducted in South Africa further highlights 
this, in that 72% of those who received a label including pictograms were found to have a 
high understanding (>90%) of the labels, compared to 15% of those who received a label 
without pictograms (Dowse & Ehlers, 2004). The use of pictograms in conveying health 
information on OTC medicine labels, however, is not currently common practice in South 
Africa. 
 
Child resistant containers (containers which an adult can open but are not accessible to 
children under the age of 5 years) have been known to reduce the number of poisonings 
from medicines, and have the potential to make adults aware of the associated risks of the 
medication (6). However, as OTC medication is usually bought off a shelf or repackaged into 
smaller packets by health provider , child resistant containers and/or labels are not usually 
included with OTC medication, making the medication label or insert of particular 
importance for providing information about safe use of the medication.    
 
1.2.2. Medication inserts 
Medication inserts provide information about each medication, which is provided by the 
manufacturer of the medication, to health workers and patients about the technical and 
medical details of the product (8). In South Africa it is compulsory that every container of 
medication be provided with a medication insert, providing essential information about the 












double sided printed piece of paper, each side printed in a different language, which in 
South Africa is English and Afrikaans. Regulation 9 of Act 101 provides an extensive 
description of the content that should be provided in the medication inserts (3). The inserts 
should include the following: Proprietary name and dosage form, scheduling status, 
pharmacological classification, composition, dosage and direction of use, contra-indications, 
pharmacological action, indication, warnings, pregnancy information, interactions, side 
effects and precautions, over dosage information, information for certain categories/ 
ingredients, presentation, storage, contact details of certificate holder, registration name 
and publication date of the insert (3). All of these details should provide the consumer with 
accurate information about the contents of the medication, who manufactures the 
medication (and how they can be contacted) as well as instructions for safe use of the 
medication (including dosage, side effects and contra-indications). All information provided 
in the medication insert is produced by the pharmaceutical company or manufacturer and 
approved by the Medicines Control Council (3). 
 
The medication leaflet is often the only resource available for accessing information about 
OTC medication in South Africa, making it an incredibly important source of information. It 
is a source of information that has the potential to empower patients through self-
medication, aiding in improving compliance and allowing patients to make informed 
decisions about their health (9). For medication inserts to be effective, the information 
needs to be readable (appropriate font size, use of language, design, etc) as well as 
understandable (in one’s first language) and culturally acceptable (10). However in South 
Africa, this is usually not the case, highlighted in a study found that on average, participants 












Many participants reported that the amount of information, the technical design and the 
type of language used in the insert was not acceptable and resulted in many participants not 
attempting to read the insert at all (9). In South Africa, there are guidelines referring to the 
content of medication inserts in the Regulation 9 of Act 101 as well as the font type and size 
(3). However, there are no guidelines referring to the size of the insert paper and insert 
design, which can result in a variety of designs between different medications. Information 
is often very technical and the language content is very difficult to understand correctly, 
even for those with adequate levels of health literacy, which could potentially be preventing 
many individuals from accessing information that is very important for their health and the 
health of their children. 
 
1.2.3. Patient Information Leaflets (PIL) 
The Patient Information Leaflet (PIL) is an information document, distributed with 
medication, which provides information about the accompanying medication in an easy to 
read format, making the information more accessible than the information provided in 
medication inserts, to the general public. PILs were formally introduced to South African 
legislation in 2003 in the Medicines and Related Substances Control Act 101 (3). A PIL 
usually includes key information on what the medication is to be used for, warnings or 
contraindications, how to take the medication, side effects, storage information and further 
information (with contact details) (11). Patient Information Leaflets have been found to 
reduce the gap between health professionals and patients, improve adherence to 
medication and reduce patient anxiety around administering of medication, however PILs 
are only effective if they match patients’ level of education and are culturally sensitive (10). 












which has been found to improve patients’ knowledge of medication, however the 
complete implementation of the PIL has often not occurred in developing countries (10).  
 
Regulation 10 of Act 101 states that all medicines distributed in South Africa should be 
provided with PILs, which requires pharmaceutical companies to develop and distribute PILs 
with all medicines (3, 12). It also provides detail as to what content should be provided in 
each PIL and states that all PILs should be printed in English and one other official language 
(13). A study conducted in Grahamstown, South Africa, evaluating the effect of PIL use on 
patient knowledge and recall, found that those who received PILs with pictograms had a 
significantly higher level of knowledge and recall (76.3%), compared to those who were just 
given text-only PILs (50.9%) and no information at all (43.3%) (14). A related study found 
that when participants were provided with an easy to read PIL, they reported to 
understanding most words in the leaflet, with all participants approving the amount of 
information contained in each leaflet, compared to average medication inserts, which are 
scientifically based and difficult to read (15). However, there has been little evidence to 
suggest that South African public hospitals have received many PILs from pharmaceutical 
companies which causes questioning as to whether these leaflets are accessible and 
available to the general public (10).  
 
Despite there being certain regulations regarding the level of information required on 
labels, medication inserts and PILs (i.e. font type and size), there are no guidelines included 
in the Act 101 which recommend how often the information found on medication inserts 
and PILs needs to be updated (3). This means that certain OTC medicines provide 












set in place to promote the increased access to information through labelling, medication 
inserts and PILs, it would seem that there is little uniformity in South Africa, with regards to 
how these regulations and policies are implemented, resulting in discrepancies between 
policy and what consumers are experiencing on an individual basis. With regards to the 
availability of Patient Information Leaflets in South Africa, it would seem that many OTC 
medications are not provided with PILs, despite legislation requirements.  
 
1.2.4. Other sources of information 
Other sources of information regarding OTC medications which are available to the public 
include the internet, advertisements and health professionals (8). In South Africa, those who 
have access to the internet can access information regarding OTC medication. One website 
in particular has been created for the purpose of making South African medication inserts 
available in electronic format, providing generic and trade names (16). According to a 
technology research organisation, Wide World Worx, only one in nine South Africans had 
access to a computer or internet in 2008, with these individuals being in higher 
socioeconomic groups due to the expense of computers.  However, with the increased 
availability of mobile phones with internet access, especially among those in lower 
socioeconomic groups, this number has increased since 2008 (17). Those living in urban 
areas who do not have access to the internet, usually have access to television which often 
advertises common OTC medications, as well as billboards, which are placed alongside busy 
roads or near communal centres, advertising OTC medications. Those who do not have 
access to these means of communication, specifically those in lower socioeconomic groups, 
often rely on information given from family or community members as well as health 












South African context, as it has been found that many patients do not feel comfortable to 
ask questions or clarify information about their medication. The presence of language or 
cultural barriers also exacerbates these difficulties (12). Within many health facilities, health 
professionals often only fluently speak English and Afrikaans, without having sufficient 
communication skills in any African languages with limited access to interpreters. Even 
when health professionals who are able to speak the first language of patients or 
interpreters are available, these services are often restricted due to terminology difficulties 
and differences in meaning (18). Many of the participants in this study who have poor 
literacy skills will most probably rely on health professionals and people in their immediate 
context (such as family members) to provide information about the correct use of OTC 
medication. Due to increased workloads and reduced consultation time in public hospital 
settings, health professionals may not be able to provide adequate verbal information to 
knowledge regarding safe use of OTC medication. Those with higher socioeconomic groups 
will usually make use of the internet to find further information if the information is not 
provided or inadequate. 
 
1.2.5. Repackaging of Medication 
 At certain private pharmacies in Cape Town, South Africa,  the pharmacists reported that 
some OTC medications are distributed in packaging which has been re-packaged to reduce 
costs, with minimal information available (19) (see Figure 1). Policy also states that all 
generic medication needs to be repackaged on site where medication is administered (i.e. 
pharmacies) (3). The repackaging of medication is also described as a service that South 
African Pharmacists and Pharmacy assistants are able to perform, highlighting the fact that 












medication is repackaged, the information that is usually given is lacking, with just the 
dosage requirements, the time of day the medication should be taken, quantity of tablets 
provided and the name of the medication. Figure 1 shows a packet of medication given to 
the researcher at a private pharmacy in Cape Town after requesting generic paracetamol. 
No other information was provided with this packaging, and when it was queried whether 
other consumers ask for additional information, the employee distributing the medication 
responded, “It’s just paracetamol, if people want something stronger they can request it”, 
which seemed to imply that there was no need for further information due to the common 





















1.2.6. South African Pharmaceutical Providers 
South Africans are able to obtain OTC medication from a variety of providers. The most 
common pharmaceutical providers include government public clinics and private chemists, 
however many individuals also purchase OTC medication, off the shelf, from commercial 
supermarkets such as Pick ‘n Pay or Clicks stores. Other providers include ‘Spaza’ shops 
which are informal traders found in predominantly township areas, as well as small corner 
shops located in most areas of the country. The amount and level of information provided 
when purchasing OTC medication from these providers varies from provider to provider, 
with some providers (such as commercial stores) consistently providing medication inserts 
alongside the medication and other providers (such as a private chemist) providing 
medication in the packet seen in Figure 1. 
 
1.3. Literacy Issues 
The United Nations Educational, Scientific, and Cultural Organization (UNESCO) Institute for 
Statistics, which defines the adult literacy rate as ‘the percentage of people ages 15 and 
above who can, with understanding, read and write a short, simple statement on their 
everyday life,’ states that in 2007, the South African adult literacy rate (males and females 
above the age of 15) was 88.72% (21). As South Africa has eleven official languages, a large 
majority of South Africans speak home languages other than English and for those who do 
attend schools, are often not taught in English (21). The 2001 census by Statistics South 
Africa reported that only 8.2% of South Africans were first language English speakers. The 
Pan South African Language Board (PanSALB) reported that in 2002, only 22% of South 
Africans were found to fully understand political, policy and administrative related speeches 












information are produced in English and on most occasions Afrikaans as well, this presumes 
that those who are literate are not able to access many forms of information which are 
needed to make informed decisions about their health. 
 
In developed countries, it is generally found that information provided with medication 
usually includes information at a higher level than the reading ability of the patient (10). It is 
important to acknowledge that individuals who have access to medication don’t necessarily 
understand it. Therefore, it needs to be highlighted that providing access to information is 
not sufficient for informing the population about safe medication use, the information 
needs to be conveyed in a way that is effective and appropriate for the context.   Low-
literacy is associated with poor understanding of one’s dis ase, poorer clinical outcomes as 
well as poor understanding of medication labels and instructions (23). When patients have 
an understanding of the benefits and potential risks of their medication, as well as an 
understanding of how to administer the medication, they are empowered to make 
appropriate decisions about using the medication safely. Patients should receive counselling 
and education in how to administer the medication, as well as the risks and benefits of the 
medication from their doctor and/ or pharmacists (24). Studies in the UK have found that in 
general, patients retain 20% of what they hear but this may increase up to 50% when 
accompanied by written information (25). Another study found that patients, who do 
receive education regarding their medication from pharmacists or physicians, struggle to 
remember this information and will rely on labels and other written information for further 
guidance (24). This, together with language and cultural barriers may result in a similar 
situation occurring in the South African context. However, many OTC medication inserts and 












for those who have poor literacy skills. This has important implications as to what 
information should be included with medications in a South African context (23). 
 
A study in Pretoria, South Africa, which looked specifically at the knowledge around aspirin 
use and use of medication inserts in the general public, found that most people have poor 
understanding or poor application of their knowledge with regards to indication, side effects 
and symptoms of overdose (8). A study conducted in the United Kingdom found that people 
often only read medication inserts or PIL’s when they had experienced a side effect, the 
medicine was for a child or the medicine was not known to them. Many found the writing 
too small and struggled with dosages, especially concerning a child (26). Given the history of 
inequality in South African education and access to information, there is still a large 
discrepancy between the educated and uneducated, as a result of past injustices. Many 
South Africans are unable to converse in English or Afrikaans and many of those who are 
able to converse, struggle to read basic information. This means that a large proportion of 
the population are not able to access information as a result of illiteracy, which further 
exacerbates their poor health outcomes.  
 
1.4. Misuse of OTC medication  
The frequent and often everyday use of OTC medication for various indications has been 
common practice amongst adults. Almost half (42%) of adults in the United States take at 
least one form of OTC medication regularly (27). The ease, at which these medications are 
accessed, as well as the potential lack of any guidance from health professionals regarding 
the correct dosage and precautions, results in the public having to rely on their own level of 












study which was carried out in 23 Cape Town specialist substance abuse treatment centres 
found that the second most frequently reported medicines which are abused or overused 
are OTC analgesics. OTC medicines as a primary and secondary substance of abuse 
accounted for 2.6% and 5.2% of all patients admitted, respectively (28). As this study was 
completed in substance abuse centres, the authors of the study suggest that the prevalence 
of OTC misuse in the general population is predicted to be more extensive than the misuse 
reported in the study.  
 
There are significant risks associated with paracetamol overdose. Other than the known link 
between paracetamol toxicity and liver failure, recent studies in the UK have found a link 
between excessive use of common OTC painkillers (including paracetamol) and headaches 
(29). Despite these associated risks, paracetamol is known to be the most commonly used 
OTC medication in the United States,  with approximately 19% of adults having admitted to 
using it on a weekly basis (27). Paracetamol overdose has resulted in more than 30 0000 
annual hospitalisations, and it has  been suggested that the cause of overdose is due to 
reduced or limited understanding of medication labelling, as well as a lack of appropriate 
understanding of daily dosages (30). A Cape Town study carried out in specialist substance 
abuse treatment centres found that the most commonly used OTC medications were 
codeine based, which are easily available in paracetamol and codeine mixtures, commonly 
sold and dispensed at shops and dispensaries.  Analgesics were the second most common 
OTC substances to be abused (28). However, in a study carried out by the poison centre in 
Tygerberg Hospital in Cape Town, South Africa, it was found that paracetamol (both 
intentional and unintentional abuse) was responsible for 14% of drugs reported to be 












poison centre in Durban, South Africa found similar findings, in that 11% of queries were 
related to paracetamol over dosage (32).  The authors largely attribute these high figures of 
paracetamol overdosing to the lay public being unaware of the potential toxicity of the drug 
when taken in overdose, which is further exacerbated by the open display of drugs in shops 
contributing to the perception that these OTC medications are safe (31). 
 
Due to overdosing and dependence on OTC medication becoming a common phenomenon, 
certain countries such as the United Kingdom and the United States have attempted to 
control the consumption of OTC medications by implementing limits on the daily 
consumption of certain products (33). Similar guidelines are followed in the USA and 
Canada. However, studies have found it difficult to determine whether this limitation has 
had any significant effect on the overuse of paracetamol amongst the population (34). 
Codeine by itself is a prescribed medication in the UK; however Codeine and paracetamol 
mixtures are sold as OTC medications in South Africa. Locally, there is no restriction on the 
number of tablets that can be sold at one time. Quantities of paracetamol tablets can range 
from 10 to 100 tablets, depending on the choice of the consumer. However, regulation does 
state that the maximum dose of paracetamol in each tablet is 500mg (35). Paracetamol is 
often distributed by public and private pharmacies in its generic form, often with little or no 
accompanying information (as seen above in Figure 1). As many forms of medication 
information have high volumes of text heavy information, which has been found to be 
confusing and difficult to follow for individuals with low-literacy skills, it is not clear in the 
literature if less intricate information accompanying medication will assist with the 
administering of medication to those with low-literacy skills (23). However, other than the 












details available to contact the provider of the medication if the consumer requires more 
information regarding the information written or regarding the information not included on 
these packages shown in Figure 1, such as contact details for the poison centre in the case 
of emergency. Consumers are not provided with any information to make informed choices 
about the ingredients, how much is administered, when it should be administered and when 
it should not be administered as well as potential side effects. This is a significant 
infringement on the consumers’ right to access to information and ability to make informed 
decisions through accessing the correct and acceptable information.  
 
1.5. Over-the counter medication use in vulnerable groups 
1.5.1. Foetuses 
There is a significant focus on certain vulnerable groups and their susceptibility for overuse 
of OTC medications in the literature. Paracetamol is one of the most commonly used OTC 
medications during pregnancy worldwide (36). Although studies relating to overdose in 
pregnancy are still largely limited to small prospective and case studies, it has been found 
that paracetamol is the most common overdose drug, usually as a result of intentional 
overdose, although unintentional paracetamol overdose has also been documented (37). It 
has been found that paracetemol can cross the placenta, resulting in its metabolism by 
foetal hepatocytes. This can result in liver necrosis if the appropriate treatment is delayed or 
not given (36). There is evidence to suggest that the maternal use of paracetamol during 
pregnancy may be a risk factor for children in the development of asthma, and this 
increased use may have contributed to the increased prevalence of asthma, worldwide, 
over the last half century (38).  Associations have been observed between the use of 












childhood (38). These studies relating to the association between paracetamol and liver 
necrosis and childhood asthma highlight the potential risks for the unborn child when 
mothers use paracetamol in pregnancy. Therefore it is important to understand whether 
pregnant women are aware of the risks of paracetamol use for their unborn child, to 
provide recommendations on how to potentially raise awareness and reduce use during 
pregnancy.  
 
1.5.2. Children  
The safety and efficacy of paracetamol has been well documented, especially compared to 
Aspirin. In the United Kingdom, use of Aspirin is not encouraged in children below the age of 
16, after associations have been found between childhood use of Aspirin and Reye’s 
syndrome (39). In South Africa, health professionals advise administering paracetamol to 
babies over the age of three months, with the recommended dose of 10 to 15mg every four 
to six hours (40). Paracetamol toxicity remains a concern, due to its increased consumption 
in children (41). Due to the perceived low risk of cough and cold medicines, the Food and 
Drug Administration (FDA) in the US recommends medical supervision when providing 
medication for children below the age of two, however despite this, inappropriate 
administration of OTC medication still accounts for a large proportion of Emergency Room 
visits which are as a result of drug ingestion (42). Data collected from Poison centres across 
the United States in 1997 found that 25% of fatal child paracetamol overdoses were as a 
result of unintentional overdose, which was usually due to lack of understanding of correct 
dosing on the part of the caregiver (41). The UK’s Medicines and Healthcare Regulatory 
Agency (MHRA) also administered guidelines recommending that OTC cough and cold 












below the age of six, however it was found that 87% of parents still administered OTC 
medication to their children and 70% of the sample misunderstood the purpose of giving 
OTC medication to children (43). In the US, it has been found that unintentional overdoses 
of medication in children are especially common with parents of a lower socioeconomic 
status and limited English proficiency (23). It is important to determine whether this is the 
case in other contexts such as South Africa with lower socioeconomic groups who also have 
limited English proficiency. 
 
The Tygerberg Poison Centre in Cape Town, South Africa, reported that varying levels of 
overdosing of OTC medication were common in children below the age of six, and this 
overdosing was usually unintentional (44). This is further highlighted in a study conducted at 
a children’s hospital in Cape Town, which found that 60% of children admitted as 
outpatients for ingesting poisonous substances were as a result of drug ingestion, with 9% 
of those admittances due to the ingestion of analgesics (45). With regards to the amount of 
calls received at the same poison centre, almost half of the calls were regarding the 
ingestion of drugs. The large amount of queries involving children as opposed to adults may 
have been as a result of the association with the hospital being a children’s hospital, 
however, it also demonstrates that unintentional poisoning is most common in children 
(45). A recent follow up study was conducted at the same Cape Town children’s hospital, 
documenting poisoning statistics between 2003 and 2008. This study found that poisoning 
as a result of drug ingestion had decreased from the study conducted in 1987, however drug 
ingestion was still the most common toxin (34% of poisonings). This decrease in reported 
poisonings was thought to be as a result of the decentralisation of health services in the 












drug ingestions reported, 8% were as a result of ingesting cold medicines and 
antihistamines, which are common OTC medications (46). An important finding from this 
study was the difference in the amount of child poisonings between different 
socioeconomic groups, with those in lower socioeconomic groups reporting more 
poisonings. This highlights the concern that unintentional poisoning from OTC medication is 
still occurring and varies between socioeconomic groups (46). These poison statistics from 
Cape Town hospitals and evidence from global and local studies highlight the detrimental 
overuse of OTC medication in children and therefore contribute to the main justification for 
choosing caregivers as the population group in this study. 
 
1.6. Gaps in literature 
The major body of literature focusing on OTC medication use and vulnerable groups focuses 
largely on the consumption habits and effects of overdose on unborn foetuses and children. 
However, there is limited research investigating the reasons as to why these unintentional 
overdoses occur and how these overdoses can be prevented. This means that further 
research needs to be done which focuses on potential reasons for overdose, such as limited 
access to appropriate information and limited health literacy needed to understand and 
apply the information provided, in order to reduce the risks when administering or taking 
medication. 
 
There is a great body of knowledge being produced from developed countries regarding 
labelling of medication, health literacy and risk of overdose with OTC medications. However, 
these countries have very different health systems and regulations in place. These countries 












levels of education and health literacy which effect choice and use of medications. The 
literature including studies from South Africa which includes health literacy, medication and 
informed decisions is largely dominated by HIV and factors affecting medication adherence. 
The literature available from South Africa which studies OTC medications in South Africa is 
outdated with only a few studies completed in the last 5-10 years and does not include 
certain groups such as pregnant women (and foetuses). Most of the literature on OTC 
medication misuse in South Africa is related to poisoning statistics, which is very relevant, 
given the severity of the problem but these statistics are not always accurate and are not up 
to date. However, from a public health perspective, it is important to look further upstream 
and investigate possible reasons as to why children are being treated for poisoning from 
unintentional overuse of OTC medications, and how these poisoning can be avoided. 
Therefore, there is a need for this topic to be researched in a South African context, which is 
unique to other contexts, so that appropriate recommendations and implementations can 














2. Aims and objectives 
2.1. Research aim 
The aim of this research is to determine whether caregivers are able to make informed 
decisions about the correct and safe administration of popular OTC painkillers to their 
children, based on information from labels, medication inserts and/or patient information 
leaflets and thereby exercising their right to access to adequate health information so as to 
reduce risks. 
 
2.2. Specific objectives 
To inform the research aim, this study has the following objectives: 
 To determine what information and in what format (e.g. labels, medication inserts 
and PILs) this information is provided to caregivers when purchasing OTC painkillers 
from various providers.  
 To explore the consumption habits (i.e. frequency of use and choice of products) of 
caregivers from various socioeconomic groups when providing OTC painkillers for 
their children. 
 To determine whether the information provided with OTC painkillers provides 
sufficient information for dosing requirements of children in the caregiver 
population. 
 To evaluate whether caregivers understand and use the information communicated 













 To determine which information (in the label, medication insert and PIL) is most 
effective and ineffective in encouraging informed decision making about use of OTC 
painkillers in the caregiver population. 
 To identify how information provision could be improved upon in order to reduce 
over and inadequate dosing of children by caregivers 
 
2.3. Research Question 
Main Research Question: 
 Are caregivers provided with sufficient and appropriate information to enable them 
to make informed risk reduction decisions when administering OTC painkillers to 
their children, thereby exercising their right to access to health information? 
 
Sub Research Questions: 
 What information is being provided to caregivers by pharmaceutical providers (i.e. 
public clinics, private pharmacies, NGOs and general stores) and is this information 
adequate for all consumers? 
 In what form is this information commonly presented? (e.g. medication insert, label 
and/ or PIL) 
 Where do individuals from respective socioeconomic groups obtain their OTC 
painkillers and why do they choose one product over another? 
 Are caregivers able to understand the dosage requirements of OTC painkillers from 
the information provided? 
 Do caregivers understand and use the risk (e.g., side effects) and safety information 












 What information in the PILs and medication inserts is most effective and ineffective 
in communicating information to caregivers, and why is this information effective or 
ineffective?   
 How can information for caregivers be improved upon in order to reduce over and 















3.1. Study design 
A cross sectional study will be conducted over two months with two groups. The first group 
will include caregivers from different socioeconomic groups who are part of different 
mothers’ groups. The second group will include pharmaceutical service providers in the 
private and public sectors of the health system in affluent and non-affluent areas of Cape 
Town, South Africa. The study will use a mixed method approach, in that both quantitative 
and qualitative research methods will be used to collect and analyse the data. The data to 
be used in this research project will be retrieved from two different descriptive cross 
sectional questionnaires, which will be administered face to face with caregivers of children 
and pharmaceutical service providers, respectively.  
 
3.2. Study population and sampling 
3.2.1. Sampling population 
Jubilee Community Church in Observatory, Cape Town, has been chosen as the institution 
from which participants will be recruited to participate in the study. This is due to the 
diverse characteristics of individuals belonging to this institution, especially with regards to 
socioeconomic status. Jubilee Community Church runs a registered clinic (Non-Government 
Organisation), in which the investigator has been involved clinically, which allows for access 
to recruit participants within the rest of the institution.  
 
Participants from the Jubilee Community Church sample live in Observatory, Salt River and 
the Southern Suburbs of Cape Town. Observatory and Salt River are suburbs with residents 












there is a mix of low, middle and high socioeconomic status groups; however Salt River 
residents usually come from lower socioeconomic contexts. Residents in these suburbs 
speak a variety of languages; however, English, Afrikaans, Xhosa and French are most 
common. The Southern suburbs (e.g. Rondebosch, Claremont and Constantia) in which 
other residents in the sample live, generally come from a higher socioeconomic background. 
As a result of previous Apartheid laws, these areas have a very high proportion of white, 
affluent residents, however all other races are found to be represented, albeit in smaller 
proportions compared to other areas of Cape Town.  
 
Participants in the group of pharmaceutical service providers will come from a variety of 
locations across the area of Cape Town, according to where the caregiver participants are 
found to purchase their medication. At this stage it is unknown where the respondents 
obtain their OTC medication from, however it is assumed that they will obtain their OTC 
medication from a public clinic (such as Woodstock CHC), an NGO clinic which is run from 
Jubilee Community Church, from private pharmacists and/ or from general stores such as 
Pick ‘n Pay or Clicks.  
 
3.2.2. Sampling strategy 
Convenience sampling will be used, in that participants will be chosen as a result of being 
part of respective caregiver groups at Jubilee Community Church which are easily accessible 
to the investigator. The investigator has access to these groups by personally knowing one 
member (or leader) of each group, who will recruit the other members of the group to 
participate in the study. The researcher aims to have an equal representation of 












representation of English, Afrikaans and Xhosa first language speakers as these are the 
predominant languages spoken in the Western Cape). 
 
Jubilee Community Church runs weekly groups for mothers with small children, and 
participants will be selected from a number of these groups that are held at the church. 
Examples of these groups include a support group for mothers living in the community, a 
health promotion group to aid development of children and a group that is run for 
caregivers who need to access the clinic to attend to the health needs of their children. 
There are a number of small support groups which will include the majority of the higher 
socioeconomic participants, with approximately six or seven members in each group.  The 
contact person for each group will explain the study process and seek informal approval 
from the group members. The investigator will then attend each group, explain the study, 
and administer the questionnaire at a time which is appropriate for each group. The health 
promotion group has approximately 15 members in the group, who are mostly in a lower 
socioeconomic status group. The investigator will attend this group to explain the study and 
process, and will then return the next week to administer the questionnaire to each group 
member. The group attending the clinic comprises of approximately 40 members, most of 
which are in a lower socioeconomic status group. Each group member is seen by a health 
professional on a specific day. On the day of the appointment, after each member has been 
seen by the clinician, the investigator will schedule an appropriate time to administer the 
questionnaire with each participant.  
 
There are various ways of measuring socioeconomic status in the literature, such as 












a scale, such as the Kuppuswamy socioeconomic scale, commonly used in India (47). 
Socioeconomic status can also be determined using the Living Standards Measure (LSM), 
however this requires knowledge of the individuals assets, according to the measure, which 
is beyond the scope of this study. For the purpose of this study, the socioeconomic status of 
participants will be defined as those in a higher socioeconomic status group having a tertiary 
education or who have completed secondary education and have an annual income above 
R50 000. Those in a lower socioeconomic status group will be defined as not having 
completed secondary education, or will have completed secondary education but their 
annual income is below R50 000. Participants in the sample could potentially be English, 
French, Xhosa and/ or Afrikaans first language speakers, but all are able to communicate in 
English as the group is run in English. Half (fifty) of the s lected participants will be from 
higher socioeconomic status groups and half (fifty) will be from lower socioeconomic status 
groups.  
 
The sample of private pharmacie , NGO and/ or clinic pharmacies used will be chosen 
according to the data collected from the caregivers in the questionnaire. These providers 
will be chosen based on the facilities from which the participants identify as where they 
primarily and regularly purchase their medication. However, it is assumed that this sample 
will comprise of a mix of public and private providers (and the registered NGO which is 
based at Jubilee Community Church) as well as larger corporate providers such as 
supermarkets and Clicks stores. A representative of each provider (e.g. pharmacist) will be 
asked to participate in filling in the questionnaire on behalf of the facility. Participants in the 
lower socioeconomic group will presumably obtain their painkillers from government clinics 












be found that some may buy in bulk from supermarkets such as Pick ‘n Pay or private 
chemists if they have the funds to purchase medication. It is presumed that participants in 
the higher socioeconomic group will purchase their painkillers from private chemists and 
corporate providers such as Clicks stores. The researcher will apply for permission from the 
Western Cape Provincial Department of Health to conduct research in a government health 
facility with consenting pharmacists. Questionnaires will only be administered once 
approval has been obtained from the Department of Health.  The information provided with 
common products purchased by participants at supermarkets will be obtained by the 
researcher, which will then be analysed and included in the discussion of the study, however 
no individuals in these stores will answer questionnaires face to face as it is assumed that 
these personnel are not trained to provide further health literacy information to the public. 
 
3.2.3. Sample size 
Based on international and South African studies (14, 24), to calculate a sample size, it is 
assumed that the caregivers will understand 50% of the information provided in OTC labels, 
medication inserts and PILs. According to the formula used to determine a sample size in a 
prevalence study (n= p(1-p)z²/ d²) where the anticipated proportion (p) is equal to 0.5  and 
assuming a precision of 10%, it was calculated that 96 participants would be needed, which 
was then rounded up to 100. Therefore, with an underlying proportion of 50%, a sample of 
100 will provide a 95% confidence interval of 40 to 60% which is narrow enough for the 
purpose of this study. The investigator aims to include 20 individuals within pharmaceutical 
facilities distributed within each study location. This number was decided by the investigator 
to be the maximum amount of pharmaceutical providers that could be feasibly included in 












dissertation level. Therefore, the sample will consist of 100 caregiver participants and 20 
pharmaceutical provider participants.   
 
3.2.4. Inclusion and exclusion criteria 
Individuals who have given informed consent will need to be 18 years or older to participate 
in the survey and therefore all individuals younger than 18 years will be excluded from 
participating in the research study. All participants need to be one of the primary caregivers 
of a child (below the age of 18) at the time of the research. Participants need to be able to 
understand and converse in English or Afrikaans, as these are the languages used to convey 
information on labels, medication inserts and PILs of OTC painkillers; however these 
languages do not need to be their first language.  
 
3.2.5. Fieldworkers 
Because most medication inserts and patient information leaflets are provided in English or 
Afrikaans and the aim of the research is to determine whether the information provided 
allows for caregivers to make informed decisions about their families’ health, the 
questionnaires will be provided in English and Afrikaans. However, some participants from 
the lower socioeconomic group may be able to converse in English but struggle to 
understand certain terminology. Therefore, a fieldworker will assist with administering the 
questionnaires when collecting data from these participants. The fieldworker, who has 















3.3. Data collection  
Data will be collected in the form of two questionnaires which will be administered by the 
researcher to all participants in the caregiver and pharmaceutical service provider samples. 
All questionnaires will be administered face to face, so as to ensure validity and equality 
amongst those who are not literate or have limited literacy.  The questionnaire will be 
provided in either English or Afrikaans, according to whichever language each participant is 
more comfortable conversing.  
 
A small pilot study will be done before the study begins to determine whether the questions 
in the questionnaire are appropriate for collecting the relevant data. The pilot study will be 
conducted as soon as the investigator has received ethics approval, and will then re-submit 
the updated questionnaire if required. The pilot study will consist of two caregivers from a 
higher socioeconomic status group, two caregivers from a lower socioeconomic status 
group and one pharmacist. The caregivers in the higher socioeconomic group and 
pharmacist are fellow Masters of Public Health students. The caregivers in the lower 
socioeconomic group are employees of two of the researcher’s colleagues. Each participant 
in the pilot study will complete an informed consent form before participating in the pilot 
study.  
 
Each questionnaire will have the participant’s respondent number and date of interview. 
The questionnaire administered to the caregivers will contain questions determining 
demographic and background information as well as questions that aim to answer the 
specific objectives of the research study. Each questionnaire will require the participant to 












their knowledge regarding OTC medication. They will then be asked to read a medication 
insert and Patient Information leaflet from a common OTC medication (Panado™) to 
determine whether they are able to understand the information being communicated to 
them. The questionnaire for the pharmaceutical service providers will include demographic 
information and questions relating to the availability and accessibility of information, their 
understanding of information provided with OTC medication, alongside the common 
practices regarding distribution of OTC painkillers to the general public.  
 
3.4. Data management and analysis 
The data will be locked in a safe location, with password computer access which only the 
researcher will be able to access and will be kept confidential at all times. All data will be 
stored in individual folders, containing the surveys, handwritten and transcribed notes of 
each participant. The researcher’s personal thoughts and observations about the caregiver 
and pharmacists’ responses given in the surveys will be recorded at the end of each day and 
if feasible, after completion of each survey. This will be done to provide clarity and richness 
to the data by documenting phenomena e.g. emotion which cannot be captured in the 
questionnaire. If the investigator is unable to continue with the research, all questionnaires 
and collected data will be destroyed.  
 
All data will be entered into the latest version of Statistical Package for the Social Sciences 
(SPSS) software and will be cleaned where necessary. The first step will be to define the 
variables used. Each respondent will have a row in the data sheet with each question having 
one column. Responses will be stored as numbers. Questions which have definite answers 












numerical value of 1, incorrect answers will be assigned a numerical value of 0. Answers 
from the questionnaires will be coded and organised into categories to be analysed. SPSS 
will be used to analyse the data as it provides flexibility in carrying out a variety of data 
analysis tasks, and therefore, is suitable for a mixed method approach (48). Variables will be 
compared using appropriate graphs and descriptive statistics will be cross tabulated using 
the information entered from each questionnaire.  
 
The qualitative data will be analysed using thematic networks analysis. The text is dissected 
and arranged into meaningful segments which are then coded. Themes are then generated 
once all the material has been coded. Similar themes are then placed into groups, which will 
eventually become thematic networks. Themes are summarized and patterns are then 
interpreted by returning to the original question and addressing the arguments that have 
arisen from the text (49). The investigator has undergraduate experience in analysing 
qualitative data and has acquired skills in quantitative data analysis through the MPH 
course.  The investigator’s UCT supervisor has vast experience in use of SPSS software and 
analysis of both qualitative and quantitative data. 
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As the questionnaires will be administered at a group that the caregivers already attend and 
at the pharmaceutical service providers’ work premises, participants will not need to be 
reimbursed for transport costs.  
 
3.6. Limitations 
There are certain limitations of the study that may affect the rigour of the research, of 
which the researcher is aware. It should be acknowledged before the research process has 
started that the researcher has no affiliations or competing interests with the subject being 
studied. The major limitation in using a cross sectional study design is the difficulty in 












which could potentially be a limitation in this study. Other limitations include budget and 
time constraints, which limit the size of the study and again possibly the external validity. 
Certain phenomena such as the effect of the researcher being present when answering 
questions may result in certain biases which cannot be controlled. Although there may be 
methodological triangulation in the mixed methods of the study, due to the nature of the 
study, there is a lack of researcher triangulation, which may also have an effect on the 
rigour of the findings.  
 
4. Ethical and Legal Considerations 
The participants will be fully informed of the research process, including methodology, 
analysis etc. and what is expected of them during the process. Each participant will be 
required to sign a letter of written informed consent which will be fully explained to them in 
each participant’s first language by the investigator (with the assistance of a translator who 
is familiar with the research process), however informed consent forms will be provided in 
English and Afrikaans as these are the primary languages spoken by the participants. This 
will be done just before the questionnaire is administered in a private room to reduce 
distractions. Participants will be encouraged to clarify information that is unclear to them 
throughout the research process, and are encouraged to ask questions whenever requiring 
more information or feeling unsure of the situation. All the information retrieved in the 
study will be treated as confidential and will only be used for the purposes of this study. All 
names and personal information will be discarded as soon as the study is complete. All 
participants will remain anonymous throughout the study to allow for confidentiality. 













Participants attending the caregiver groups will be provided with remuneration according to 
the needs of the respective groups and average socioeconomic status of the group 
members. For example, those attending the developmental stimulation group (lower 
socioeconomic status) will be provided with a session, run by the researcher (a registered 
Occupational Therapist), which will provide simple home activities to aid in gross and fine 
motor development. A donation will be made to the clinic for their service provision.  All 
participants will also be given further information with guidelines on safe administration of 
medication with children, although those in higher socioeconomic status groups will only be 
provided with the information, and no other monetary remuneration. This will be provided 
in the form of a paper hand out and will be developed by combining existing material on 
safe administration of medication, together with pictograms and simple instructions 
developed by the investigator. Participants from pharmaceutical service providers will be 
provided with the findings of the study and recommendations for future practice regarding 
provision of adequate information to caregivers administering OTC medication to their 
children. The study promotes the concept of justice as it may be used to provide more 
information which is rightfully due to the population. There are no overt risks for individuals 
who participate in the study. This study complies with the latest version of the Declaration 
of Helsinki (2008) as well as the Department of Health: Ethics in Health Research: Principles 
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1. Introduction and objectives of literature review 
Unintentional overdosing with over-the-counter (OTC) medications has become an 
increasing global public health concern, due to the common and frequent use of these 
(especially painkillers) and end users’ perceptions of these being low risk drugs. Almost half 
(42%) of adults in the United States take at least one form of OTC medication regularly (1). 
As a result, some higher income countries have attempted to address this concern by 
reducing the quantity of medication available to the consumer and providing greater access 
to health information (2). However, despite the increase in use of OTC medication, many 
consumers in middle and low income countries still do not have access to enough 
information when obtaining their OTC medicines, hindering their ability to make informed 
decisions about OTC medication use.  
 
In South Africa, a large proportion of unintentional overdoses from OTC painkillers occur 
among children, which can often be attributed to incorrect dosing from caregivers (3). 
Recent studies from poison centres in South Africa have found that medications are the 
most common toxins ingested by children, with analgesics, specifically paracetamol, 
accounting for a large proportion (10-15%) of these overdoses (3).  With the common 
practice of re-packaging medications at a distribution level, detailed risk and dosage 
information is often not included with the medication. When information is provided, only a 
small minority of caregivers receive information in their first language, with even fewer 













The purpose of this research study was to determine whether caregivers are provided with 
adequate dosing and risk information about popular OTC medications, specifically 
paracetamol, thereby allowing them to make informed risk reduction decisions about their 
own health and their families’ health. 
 
To inform this research, the objectives of this literature review included: 
 To determine the current regulations, policies and guidelines concerning provision of 
information with OTC painkillers in South Africa which guide and keep service 
providers accountable when providing health information. 
 To determine the extent of overdosing of OTC painkillers internationally and in South 
Africa, specifically in children with paracetamol. 
 To determine the barriers which prevent OTC painkiller users from making informed 
decisions, internationally and in South Africa. 
 To determine the factors which encourage informed decision making in consumers 
using OTC painkillers. 
 
2. Search strategies 
The following strategy was followed to search for literature which informed this study: 
 
Strategy: Relevant search engines were used to search for terms relating to the topic. Once 
relevant articles were found, the journals in which these articles were published were 
searched further using the same criteria. Journal article titles relating to the search terms, 












informal material, such as newspaper articles, were also considered. Only peer reviewed 
articles which were published in online journals were reviewed. 
 
Search engines: Primo UCT, Academic Search Premier, Google Scholar, Pubmed, EBSCOhost, 
Science Direct, Swetswise. 
 
Inclusion criteria: Studies which included OTC painkillers, health literacy, information and 
medication use, child dosing, poisoning, and informed decision making. 
 
Exclusion criteria: Studies not written in English and studies published before 1985. Articles 
not peer reviewed.  
 
Search terms (categorised by search area):  
 Overuse of OTC medication: children and painkiller poisoning or overdosing, 
paracetamol and overdose and children, OTC poisoning and children. 
 OTC regulations in South Africa: OTC medication and information or Patient 
information leaflet or medication insert or label and South Africa, OTC medication 
and legislation 
 Health literacy and health communication: health literacy and OTC medication, 
informed decisions and medication, literacy and access to health information, health 
literacy and painkillers, health and communication and medication, labels and 
literacy, comprehension or understanding and medication or information, readability 













3. Summary of literature review 
3.1 Extent of OTC medication overdose 
The common overuse of OTC medication, both intentional and unintentional, amongst 
adults and children, has been frequently described in international and South African 
literature over the last fifteen years (1, 4-7).  In terms of overdosing with OTC pain 
medication, the literature suggests that paracetamol is responsible for a large proportion of 
these overdoses (4, 5, 8, 9). The increased availability and lack of awareness of the effects of 
overuse are both factors which contribute to end users overdosing on the drug.  
Paracetamol overdose leads to more than 300,000 hospitalisations in the United States each 
year (6). In South Africa, the findings have been similar. In two studies carried out by the 
poison centre in Tygerberg Hospital in Cape Town, South Africa, paracetamol was found to 
be the most common exposure in analgesic poisoning (3, 10). These findings are further 
supported by a study conducted in a poison centre in Durban, South Africa which found that 
11% of queries were related to paracetamol over dosage (9). These studies indicate that 
paracetamol plays a significant role in OTC drug overdoses in South Africa, which warrants 
research on consumers’ perceptions and use of paracetamol, as well as their access to 
important health information about the painkiller.  
 
Most overdosing cases documented in recent local and international literature are related 
to vulnerable groups, specifically children, pregnant women and their foetuses (11, 12). 
Paracetamol is one of the most commonly used and overused OTC medications during 
pregnancy worldwide. Despite studies relating to overdose during pregnancy being limited 
to small prospective and case studies, paracetamol was indicated as the most common 












paracetamol overdosing has also been documented (8). Although a Nigerian study 
determining the extent of paracetamol overdose in children found that only 1.7% of 
caregivers overused paracetamol, other studies have found greater proportions of child 
overdosing (13). For example, at a children’s hospital in Cape Town, 60% of children 
admitted as outpatients for ingesting poisonous substances were from drug ingestion, with 
9% of those admittances due to the ingestion of analgesics (14). A recent follow up study, 
documenting poisoning statistics between 2003 and 2008 found that drug ingestion 
(including analgesics) poisoning had decreased (due to a decentralisation of health services) 
from the study conducted in 1987, however drug ingestion was still the most common toxin 
(34% of poisonings) with analgesics, making up 15.8% of analgesic overdose cases (10). 
Despite the differences in prevalence of paracetamol overuse, the literature still highlights 
the common overdosing of children with paracetamol. This significant problem of 
paracetamol overdosing in children led to caregivers being the main focus group in this 
study.  
 
There are several potential reasons for the increased prevalence of paracetamol overdosing 
in South Africa. Currently, there is no limit in the amount of paracetamol that can be bought 
from shops or pharmacies, and if information is provided with paracetamol, warnings are 
often not clear enough to convey the risks associated with excessive paracetamol use. As 
children are reliant on caregivers for the provision of medication and treatment, it is 
important to determine whether caregivers are provided with risk information and whether 
this information is appropriate, particularly for dosage and side effects. This information is 
provided through mechanisms, including labels, medication inserts and Patient Information 












3.2. Current regulations and difficulties with access to medication information 
In South Africa, Act 101 of the Medicines and Related Substances guidelines clearly states 
that medication information should be communicated by means of labels, medication 
inserts and PILs). According to legislation, “all medicine intended for administration to 
humans shall have a label attached to it, with each package accompanied by a medication 
insert and (PIL) (11). These three mechanisms of communication are important as they are 
the primary means of communicating risk and health information to consumers. According 
to the Act, all three mechanisms of information should be provided in English and another 
official language (11), however many end users are still not able to access this information in 
their first language. It is therefore important to determine whether end users have access to 
information in a language that they can understand and furthermore, if they are able to 
understand the specific language being used in the text. 
 
Medication insert 
The medication insert has the potential to empower patients self-medicating by aiding in 
improving dosage compliance. (15) The insert comes in the form of a double sided printed 
piece of paper, each side printed in a different language, which in South Africa is English and 
Afrikaans. The 2001 census by Statistics South Africa reported that only 9.6% and 13.5% of 
South Africans were first language English and Afrikaans speakers, respectively, with a large 
proportion of the population speaking isiZulu and isiXhosa (22.7% and 16%, respectively) 
(12). This means that only 23.1% of the population have the potential to access health 
information in their first language (assuming they read the information), while those from 
the other official language groups do not. The literature is not clear about how often 












not known how many consumers actually have access to inserts. However, for those who do 
have access to these inserts, it is estimated that less than 23% of the South African 
population is able to fully access health information due to difficulties with health literacy 
(discussed later in this paper).  
 
Patient information leaflet 
The Patient Information Leaflet (PIL) is an information document, distributed with 
medication, which includes simple non-scientific, everyday language with a clear format, to 
provide risk and dosage information to consumers with a variety of health literacy levels. 
PILs have been implemented throughout the developed world, which has been found to 
improve patients’ knowledge of medication. However, PILs are still not being provided with 
medication in middle and low income countries (16). Act 101 states that all medicines 
distributed in South Africa should be provided with PILs (11). It also states that all PILs 
should be printed in English and one other official language, which has potential for greater 
access to information than the medication insert which is only printed in English and 
Afrikaans (8). However, there has been little evidence to suggest that South African public 
hospitals have received many PILs from pharmaceutical companies which leads to the 
question as to whether these leaflets are accessible and available to the general public (16).  
 
Label 
Act 101 states that the container of every medicine intended for human use must have a 
label clearly attached to it in English and one of South Africa’s other eleven official 
languages (11). However, labels are predominantly written in English, resulting in many 












The container label should provide basic information about the medication such as the 
medication’s name, patient’s name, dosage, instructions, indications, special instructions 
and general warnings and is created by the manufacturer of the medication (11). Despite 
labels being the primary source of information for OTC medication users in more developed 
countries (17), the literature is not clear about the extent to which labels are currently being 
used and distributed with OTC medication in South Africa.   
 
Regulations regarding risk communication outlined in Act 101 of the Medicines and Related 
Substances guidelines are in place to protect consumers; however, if they are not 
implemented correctly, consumers are at risk of causing significant harm to themselves and 
their families. In certain South African settings, medication inserts often do not accompany 
the medication, making the label incredibly important, as it is the consumer’s only means of 
access to information. However, in South A rica, warnings are often missing on labels 
distributed with OTC medication and labels are predominantly produced in English, which is 
not the first language of the majority of users. The literature clearly highlights the 
importance of the label, medication insert and PIL and that there is sufficient South African 
legislation in place to encourage access to this information. However, further investigation 
needs to be done to determine whether end users have access to this information and/or 
why end users are not able to understand and use the provided information appropriately. 
 
3.3. Factors influencing informed decision making  
The literature is clear about what factors influence informed decision making, specifically 
relating to the use of labels, medication inserts and PILs. These include the format of the 












well as one of the most important factors - the end users’ ability to comprehend the 
information.  
 
Format of information:  
The United States Pharmacopeia (USP) recently released universal standards for medication 
labels in containers dispensed by pharmacists (18). The standards emphasize the use of high 
contrast print, large font size, prudent use of white space and prominent placement of 
important information (18). This is supported by other studies in the United States, which 
have found that readability of labels and inserts can be increased by having larger font, 
boldfacing, use of white spacing between words and aesthetically pleasing designs (19, 15, 
16). The World Health Organisation, on the other hand, do s not focus on the use of words 
at all and has found pictograms (for example, a picture of the number of spoons of medicine 
to administer to a child) to be particularly effective in attracting attention, reminding 
consumers of safety messages already known and aiding in conveying messages that are 
difficult to describe in text, especially for those who have limited health literacy (20). A 
study conducted in South Africa further highlights this, in that 72% of those who received a 
label including pictograms were found to have a high understanding (>90%) of the labels, 
compared to 15% of those who received a label without pictograms (16, 21). Currently, 
information accompanying paracetamol in South Africa (both generic and brands) do not 
have pictograms. 
 
Parent-physician communication:  
 International studies have found that a combination of parent –physician (or pharmacist) 












make informed decisions about their children’s medication (22, 19). Studies in the UK have 
found that in general, patients retain 20% of what they hear but this may increase up to 
50% when accompanied by written information (23). However, a study by Shrank and Avorn 
found that patients, who receive education regarding their medication from pharmacists or 
physicians, struggle to remember this information and will rely on labels and other written 
information for further guidance (24). Culture also tends to mould health beliefs such as, 
what is deemed to be appropriate behaviour of the health provider and effective treatment 
for certain conditions/ illnesses. Other cross-cultural difficulties include problems with 
certain words not existing in some languages, or having a different meaning.  Accessing 
information from health professionals does prove to be difficult in a South African context, 
as it has been found that many patients do not feel comfortable to ask questions or clarify 
information about their medication and the presence of the previously mentioned language 
or cultural barriers also exacerbates these difficulties (25, 26). This study seeks to determine 
whether pharmacists consider verbal counselling to be as, or more important than written 
information, as this will determine how much verbal counselling is provided by respective 
pharmacists. It is important to determine whether South African caregivers are provided 
with verbal instructions from health professionals when obtaining their OTC medication or 
whether users need to rely purely on written information.  
 
Health and risk communication:  
It is widely accepted that information and communication together, are imperative in 
determining whether people make decisions to engage in suggested health behaviours and 
whether these behaviours have positive outcomes (27). The way in which risks are 












according to the known risks and benefits of OTC medication. However, for risk to be 
communicated effectively, it is important to determine what motivates individuals to 
change their health behaviour. There are a number of models and theories (Health 
Behaviour Model, Health Action Process Approach, Protection Motivation Theory and 
Expectancy Value Theory) which highlight perception of risk as one of the core reasons for 
individuals adopting certain health behaviours (28, 29, 30). These theories suggest that most 
health behaviour is motivated by the perceived benefits and barriers to adopting certain 
behaviours as well as the perceived magnitude of a threat, if certain behaviour is not 
adopted. The way in which individuals perceive the benefits, barriers and threats of 
behaviour change is largely affected by the effectiveness of how risk is communicated. Glik 
(2007) highlighted several guidelines for effective risk communication. These guidelines 
stressed the importance of the following: 
 Consistency of the message 
 Accuracy of messages, as past errors result in people not responding to subsequent 
risk information 
 Information being specific, so that the end users are provided with precise details on 
‘what’, ‘how’, ‘when’ and ‘how long’. 
 Adapting information to the diverse audiences they intend to reach, specifically 
considering their cultural, social and economic norms. (31)  
Effective risk communication should meet the specific needs of all populations, especially 
those at greatest risk (most vulnerable) and most likely to experience difficulties with 
communication (32). One of the most important factors when communicating risk is the 
ability to establish trust with the public. If the public does not trust the providers of 












34). This trust is largely linked to social and culture values within the public groups and has a 
large effect on how risk messages are accepted and utilised. The social constructionist 
approach suggests that risks cannot be studied in isolation, but rather within a larger socio-
cultural environment highlights how different groups perceive and value risks differently 
(32). These are important concepts to consider when determining what information is 
provided to OTC end users and whether this information is effective in conveying messages 
to end users in a variety of social, cultural and economic groups. This is especially important 
in the South African context where risk needs to be communicated to a variety of socio-
cultural groups, with differing perceptions and values placed on risk.  
 
Comprehension of information:  
The link between literacy levels and comprehension of information has been well 
documented in the literature. Health literacy has been defined as ‘the cognitive and social 
skills which determine the motivation and ability of individuals to gain access to, understand 
and use information in ways which promote and maintain good health’ (35). Health literacy 
plays a large role in understanding the name, dosage, side effects and indications of 
medication, with there being a large association between educational background and level 
of understanding of medication information (36). A study conducted in Nigeria found that 
those who were educated up to secondary and tertiary level provided correct doses of 
paracetamol to their children (13). However, in the US it has been found that many of those 
groups perceived to be ‘educated’ and able to understand verbal health information and 
instructions, are not necessarily able to fully understand written health information. These 
individuals may have highly functional literacy levels, but have low health literacy levels, 












information, but struggle to understand language used in health information. These are the 
individuals who are often overlooked or unaccounted for, as they are perceived to be able 
to understand health information provided to them, yet in reality, they are covertly being 
denied access to important risk and dosage information (37). The 2003 National Assessment 
of Adult Literacy focusing on Americans’ ability to understand health-related information 
found that only 15% of the participants had proficient health literacy skills needed to 
prevent disease by managing their medication appropriately and understanding their 
respective health conditions (38). The same study found that low parent health literacy was 
an independent predictor for having difficulty understanding OTC medication labels (38). 
Another study conducted in the US found that caregivers with inadequate health literacy 
were more likely to use non-standardized dosing instruments when providing liquid 
medication to their children, compared to caregivers with adequate health literacy. These 
caregivers with lower health literacy levels were also less likely to have adequate knowledge 
about weight-based dosing, compared to the caregivers with adequate health literacy (38). 
The international literature highlights caregivers’ difficulty with comprehending health 
information, as a result of limited health literacy. Similar difficulties are also prevalent in 
South Africa. The United Nations Educational, Scientific, and Cultural Organization (UNESCO) 
Institute for Statistics, reported that in 2007, the South African adult literacy rate was 
88.7%, which is considered to be relatively high, compared to other middle income 
countries (39). However, a study in Pretoria, South Africa, which looked specifically at the 
knowledge around the use of aspirin and medication inserts in the general public, found 
that most people have poor understanding or poor application of their knowledge with 
regards to indication, side effects and symptoms of overdose (40).  With many South 












these factors further exacerbate their potential difficulties in accessing information so that 
the appropriate recommendations for policy planning and implementation can be put forth. 
 
4. Gaps in literature 
The major body of literature focusing on OTC medication use and vulnerable groups focuses 
largely on the consumption habits and effects of overdose on unborn foetuses and children.  
However, there is limited research investigating the reasons why these unintentional 
overdoses occur and how these overdoses can be prevented. There is a great body of 
knowledge being produced from developed countries regarding this subject, yet very little 
being produced in developing countries such as South Africa. This could be due to limited 
funding as well as a lack of clear legislation regarding information provision. Further 
research needs to focus on potential reasons for overdose, such as limited access to 
appropriate information and limited health literacy needed to understand and apply the 
information provided.  
 
5. Need for further research 
The majority of OTC medication literature regarding labelling of medication, health literacy 
and risk of overdose focuses on developed countries such and the United States and United 
Kingdom. However, these countries have very different health systems and regulations in 
place, which means that these studies may not be valid in a middle income country. The 
literature from South Africa which includes studies on medication, health literacy and 
informed decision-making is largely dominated by HIV and factors affecting medication 
adherence. This is understandable, due to the high prevalence of HIV in South Africa, 












contexts. The OTC medication literature available from South Africa is outdated with only a 
few studies completed in the last 5-10 years and does not include certain groups such as 
pregnant women (and foetuses). Most of the literature on OTC medication misuse in South 
Africa is related to poisoning statistics, which is very relevant, given the severity of the 
problem, but these statistics do not capture those individuals who do not end up being 
considered overdose cases. From a public health perspective, it is important to look further 
upstream and investigate possible reasons as to why children are being treated for 
poisoning from unintentional overuse of OTC medications, for example, paracetamol, and 
how these poisoning can be avoided. Being in a lower socioeconomic group is a risk factor 
for exposure due to decreased supervision of children, lack of education and small homes 
with limited storage facilities (41). However, it is unknown whether the information 
provided, or lack thereof, further exacerbates the misuse of OTC medication among certain 
groups.  Therefore, there is a need for this topic to be researched in a South African context, 
so that appropriate recommendations and policy can contribute to preventing overdosing in 
children. 
 
6. Contribution of research to literature 
The legislation which guides how and what information should be provided with OTC 
medication is available, however various factors hinder end users from being able to 
appropriately use and understand the information provided. This research aims to 
investigate what the missing factors could be, so as to provide recommendations to policy 
makers and encourage more effective risk communication. The limited research that has 
been conducted around this topic in South Africa has looked at whether people are able to 












specifically designed for the purposes of their study, for example, a PIL created to determine 
whether use of the pictogram improved adherence to Anti-Retroviral treatment) and what 
factors have an effect on this understanding. This research aims to determine what 
information is being provided to caregivers and whether this information fosters informed 
decision-making. As most of the research has focused on adults and the effect of literacy 
and informed decision making on their own health, this research aims to provide further 
insight into whether caregivers are able to provide appropriate treatment to their children, 
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PART C: ARTICLE 
“But it’s just paracetamol”: Caregivers’ ability to administer over-the-counter painkillers 
to their children with the information provided.¹ 
Abstract  
Objective: To determine whether South African caregivers are able to make informed 
decisions about their families’ use of over-the-counter (OTC) painkillers, through access to 
and use of labels, medication inserts and/or patient information leaflets (PILs). Methods: A 
cross sectional, face-to-face questionnaire was administered to sixty caregivers and seven 
pharmacists in Cape Town, South Africa. Caregivers were requested to answer questions 
related to paracetamol labels, inserts and PILs provided. Results: Most caregivers receive 
labels with their painkillers with few respondents having received or ever seen PILs. The 
majority of respondents who received inserts were from a higher socioeconomic group. 
Caregivers found it difficult to understand the scientific terms in all three mechanisms of 
information provision. Eighty percent of respondents found the study PIL easiest to 
understand, yet PILs are largely unavailable in South Africa. Ten percent of literate 
respondents were unable to understand the dosage requirements for children. Conclusion: 
Most caregivers are not able to make informed decisions from the information provided, 
due to limited provision of information and health literacy, potentially placing their children 
at risk of being overdosed with OTC painkillers. Policy makers need to consider end users’ 
levels of health literacy when creating and implementing health information policies. 
 
Keywords: Overdose, children, South Africa, health literacy, OTC drugs 
¹Patient Education and Counseling suggest that Tables and Figures should be uploaded as separate table files and separate figure files. For 













The increase in self-medication with over-the-counter (OTC) medicines in middle and low 
income countries has resulted in consumers using OTC medicines to medicate themselves 
and their children without fully understanding the associated health risks. As OTC 
medication (for example, painkillers and cough medicine) in South Africa, and other low and 
middle income countries, can be purchased without any verbal information provided by a 
health professional, end users rely predominantly on written information accompanying the 
medication about how to self-medicate and medicate others. International studies have 
found that those who use written sources of information have increased knowledge about 
the medication, however less than half of end users can fully understand this written 
information (1). The worldwide increase in overuse and distribution of OTC medication over 
the last 15 years (2-7), together with limited verbal information from health professionals, 
has contributed to the increase in unsafe behaviours (such as overdosing) due to users not 
being aware of the risks and having a decreased understanding of the accompanying 
information (1).  Thus it is important to determine whether end users have access to 
adequate information, equipping them to administer OTC painkillers safely themselves and 
to their families, while understanding the associated risks of the medication.  
 
In South Africa, OTC medication can be obtained from government clinics, private 
pharmacies, general stores and ‘spaza’ shops (informal convenience shops, usually run from 
home), all of which will provide different, and often limited, information with the 
medication. There are three major and legally required health communication mechanisms 
for providing end-users access to dose and health risk information, namely a label, 












are created by the manufacturer and approved by the Medicines Control Council (8). The 
label provides basic information about the medication, while the medication insert contains 
scientific information appropriate for use by health professionals. The PIL is written in lay 
language to provide simple but sufficient information to the end user. In many developed 
countries, most OTC medicines are only accompanied by a label and PIL. Common practice 
in South Africa, however, is that OTC medication is provided without any of these three, 
especially when the medication is repackaged by government clinics or pharmacists, when 
none are provided. Despite the existence of three different and quite thorough mechanisms 
for providing medical and risk information to consumers, overdosing and overuse, especially 
of children, continues. 
 
Table 1 
SA Legislated Information Provision Requirements for OTC Medication (8) 
Information Provision Mechanism                  Information Required 
 
Label  The label, stuck to the container, provides basic information 
about a medication such as the product name, patient’s 
name, dosage instructions, indications, special instructions, 
general warnings, ingredient list and date on which the 
medication is dispensed.  
 
Medication Insert The insert comes in the form of a double sided printed piece 
of paper in the box holding the container, each side printed 
in English and one other official language (usually Afrikaans) 
respectively. The insert includes the following: Proprietary 
name and dosage form, scheduling status, pharmacological 
classification, composition, dosage and direction of use, 












warnings, pregnancy information, interactions, side effects 
and precautions, over dosage information, information for 
certain categories/ ingredients, presentation, storage, 
contact details of certificate holder, registration name and 
publication date of the insert.  
 
Patient Information Leaflet (PIL) The Patient Information Leaflet (PIL), given to consumers by 
the manufacturer of the medication, provides information 
about the accompanying medication in an easy to read 
format, making the information more accessible than the 
information provided in medication inserts or labels, to the 
general public. It is to be printed in English and one other 
official language and includes key information on what the 
medication is to be used for, warnings or contraindications, 
how to take the medication, side effects, storage 
information and further information (with contact details).  
 
Low-literacy has been found to be associated with poor understanding of one’s disease, 
poorer clinical outcomes as well as poor understanding of medication labels and inserts (9 -
12). A study conducted in Italy found that functional health literacy (that is ‘the cognitive 
and social skills which determine the motivation and ability of individuals to gain access to, 
understand and use information in ways which promote and maintain good health’) (13), 
was directly associated with education level, with those educated having higher health 
literacy levels than those who were less/ not educated (1). An individual’s level of health 
literacy plays a key role in understanding the dosage, side effects and indications of 
medication, with there being a significant association between educational background and 
level of understanding of medication information (1, 14, 15).  In 2007, the South African 
adult literacy rate was 88.7%, (16) however; due to the low health literacy levels of many 












medication information , even if they are provided with all forms (written and verbal) of 
information (17). This places many South African medication users at risk of overdosing on 
prescribed and OTC medicines such as paracetamol.  
 
 Despite its documented safety and efficacy, paracetamol toxicity remains a public health 
concern, especially due to its increased consumption by children (18-21). Paracetamol 
overuse and overdosing has been linked to liver failure, headaches and development of 
asthma in children (22, 23). In studies conducted in South Africa, one study found that 
paracetamol was responsible for between 10-14% of drug overdoses and another study that 
paracetamol was the most common drug in analgesic poisoning amongst children (24, 25, 
26). However, despite the health risks associated with paracetamol overdose, the lay public 
are often unaware of the potential toxicity (24). Perceptions that this is a low risk drug are 
highlighted in the response of an employee at a South African pharmacy, who when asked 
for more information to accompany a repackaged packet of paracetamol responded; “but 
it’s just paracetamol…”. As many consumers rely on pharmacists for verbal counselling 
regarding their OTC medication, this response could further exacerbate the lack of 
perceived danger in using paracetamol with children. 
 
The literature attributes the overuse of paracetamol in South Africa to its accessibility as a 
non-prescription drug (25, 26). However, it is unclear whether it is merely the accessibility of 
the drug or lack of appropriate information accompanying it, which contributes to this 
overuse, or both. There are a number of models and theories (Health Behaviour Model, 
Health Action Process Approach, Protection Motivation Theory and Expectancy Value 












health behaviours (27-29). That is, health behaviour is motivated by the perceived benefits 
(e.g., pain relief) and barriers (e.g., monetary expense) to adopting certain behaviours as 
well as the perceived magnitude of a threat (e.g., lack of pain relief) if certain behaviour is 
not adopted. The way in which individuals perceive the benefits, barriers and threats of 
behaviour change is largely affected by the effectiveness of how potential risks are 
communicated (27-29). The literature also suggests that in order for risk communication to 
be effective, information needs to be accurate, consistent, specific and appropriate for the 
diverse audience it intends to reach. This begs the question as to whether the three written 
forms of risk information available for paracetamol in South Africa are appropriate for all 
users. Effectiveness is also reliant on the end users’ ability to trust the information provider 
(30, 31). Clamusa and colleagues found that 10-65% of OTC medication users in Italy were 
not fully aware of several risk areas including drug interactions and misuse. It is important to 
know whether similar results would be found amongst South Africans. (1) That is, 
particularly to explore caregiver perceptions of risk and understanding of medical 
information so as to prevent overdose and overuse especially from common painkillers such 
as paracetamol. This article, therefore, presents research findings on determining whether 
caregivers in South Africa were able to make informed decisions about dosing and use of 
paracetamol, specifically through the access to and comprehension of labels, medication 
inserts and/or PILs.  
 
2. Methods 
2.1. Study area 
This study was conducted between December 2012 and January 2013 in a Christian Church 












from its premises and is home to approximately 10-20 informal mothers’ groups. This site 
was chosen due to the diversity of the individuals taking part in these groups to provide a 
varied perspective. The pharmaceutical service providers, from where the caregivers 
purchased their OTC medication, were situated in close proximity to the church. 
 
2.2. Study population 
Convenience sampling was used to recruit fifty nine caregivers from different socioeconomic 
groups and nationalities who were part of five mothers’ groups. The Church has a number of 
informal ‘mothers’ groups’ which provide support for mothers with children ranging from 
newborn to approximately eight years old. Study participants needed to be 18 years or older 
and one of the primary caregivers of a child. Participants also needed to be able to 
understand and converse in English or Afrikaans, as these are the current languages used to 
convey information provided with OTC painkillers; however these languages did not need to 
be their first language.  
 
The study sample also included seven pharmaceutical service providers in the private (n=3), 
public (n=3) and NGO (n=1) sectors of the health system. These represent the providers 
used by the study participants (and greater South African public) chosen according to where 
the caregivers reported to obtaining their OTC medication. As the code of conduct for 
Pharmacists (2008) clearly states that all patients should receive advice (often through 
means of further counselling) on the safe use of medicine, it was important to determine 
the role of pharmacists in the provision of information to caregivers (32). As this study was 
conducted for fulfilment of degree purposes, the sample number was calculated according 












2.3. Study design 
A cross sectional face to face questionnaire (Figure 1) was designed by the researchers and 
approved by the University of Cape Town’s Health Sciences Faculty Research Ethics 
Committee.  The questionnaire, piloted and revised accordingly, was administered to 
caregivers (N=59) in higher (n=30) and lower (n=29) socioeconomic groups.  Each caregiver’s 
socioeconomic status was determined by their self-reported level of education and income. 
For the purpose of this study, those in a higher socioeconomic status group had a tertiary 
education and/or earned higher than R50 000/ annum. Those in a lower socioeconomic 
status group had not completed secondary education or they had completed secondary 
education but had an annual income of below R50 000. Qualitative and quantitative data 
were collected and analysed using mixed techniques , specifically a ‘complementarity’ mixed 
method approach, where the qualitative and quantitative methods measured the different 
and overlapping aspects of the same phenomenon. This resulted in a richer, more in depth 
understanding of the phenomenon being studied, which in this study is whether caregivers 
were provided with enough information to make informed decisions (33). This approach 
aimed to seek clarification and elaboration of results from the qualitative data with the 
results from the quantitative data. In this study, the quantitative data was used to quantify 
where caregivers received their information, how often they received it, how well they 
understood the information, etc. The qualitative data served to elaborate further and 
contributed to the understanding of the quantitative results to determine for example, the 
reasoning behind the caregivers’ choices or perceptions of types of information which 














Figure 1  
Examples of questions provided in each section of caregiver questionnaire (available upon 




Where do you usually get painkillers for your children and why? 
Do the painkillers that you buy come with a label, medication insert and/ or PIL? 
Medication Insert Example Questions 
What is the maximum amount of Panado™ (paracetamol) a child (age 6-12 years) is allowed in one 
day? 
What do you think about the size of the writing on the page? 
Patient Information Leaflet Example Questions 
 Is it safe to take this medication when you are breastfeeding? 
 What does the term ‘side effect’ mean? 
Medication Label Example Questions 
Is it safe to give this medication to a child under the age of 6 years? 
Do you think there is any information missing from this label?  
Previous poisonings 
Has your child ever taken too much medication? 
Improving Information Provision 
Which form of information (PIL, medication insert or label) do you find easiest to read? 
Would you find the information easier to understand if it was written in another language other than 
English/ Afrikaans? 
Do you think over-the-counter medicines are dangerous?   
 
 
2.4. Data collection 
The interviews took place at a church (with a clinic) in Cape Town, South Africa. This location 












mothers group was approached via a contact person who was either known to the 
researcher or suggested by other caregivers participating in the study. Each questionnaire 
was written in English and was administered by the researcher or trained field worker.  Each 
questionnaire incorporated quantitative methods e.g. quantifying how often caregivers 
received respective pieces of medication information, as well as qualitative methods (in the 
form of open ended questions) to gather data. The interviews were approximately 45 – 60 
minutes long with each participant only being interviewed once.  A representative working 
for the seven pharmaceutical service providers was randomly approached by the researcher 
when entering the facility (the representative was usually the first pharmacist to make 
contact with the researcher) and invited to participate in the study. The questionnaire was 
verbally administered to each caregiver and pharmacist after written consent was given. 
Each caregiver participant was provided with informal feedback after each questionnaire 
was completed. 
 
Each questionnaire required the caregiver to read the medicine information provided (to 
determine level of literacy) and answer questions about their general use, knowledge and 
perceptions of OTC medication when administering to their children (Figure 1). One 
participant did not administer OTC painkillers to her children, resulting in that questionnaire 
being discontinued. The remaining 59 participants were asked to read a Panado™ (i.e., 
paracetamol) medication insert and label (on an actual box), as well as a paracetamol PIL 
produced in the UK (this was due to the researcher being unable to find a PIL accompanying 
South African paracetamol medication) (Figure 2). The questionnaire for the pharmaceutical 
service providers included questions relating to the information they provide, alongside the 












Figure 2  
Photographic description of Paracetamol medication insert and PIL 
 
 
                                   
               Fig 2.1 Product Medication insert           Fig 2.2 Product PIL 
 
2.5. Analysis 
The data was captured using SPSS21 to calculate the results and analyse emerging themes 
from the qualitative data. The researcher documented relevant themes based on the 
literature which emerged as data was captured. Answers from questions determining the 
caregivers understanding of each form of information, were either classified as correct or 
incorrect to determine their level of information comprehension. Questions which had 
definite answers were categorised as either correct with a numerical value of 1 or incorrect 
with a numerical value of 0. Descriptive statistics were used to determine the frequency of 















2.5.6 Research quality 
From a qualitative perspective, the strategies to ensure confirmability and dependability 
included the use of theory and literature as well as a careful protocol to guide the formation 
of the questionnaire. Researcher triangulation was encouraged by having three different 
sources (student, supervisor and assistant fieldworker) involved in the project. The study 
aimed to have a sufficient degree of generality by providing theoretical insights which arose 
from the study that could be projected to other contexts, thus encouraging transferability of 
findings. 
 
From a quantitative perspective, there were a number of strategies used to ensure 
reliability and validity (external & internal).  Information bias was reduced by using the same 
measure (questionnaire) for all participants and having one prominent researcher which 
meant that the questionnaire was asked in a consistent way throughout the study 
(encouraging internal validity). Selection bias was minimized by having limited non-
responses or loss to follow up, which also allowed for greater internal validity. Reliability of 
the questionnaire was increased by conducting a pilot study. 
 
From a mixed method perspective, legitimation was encouraged in a number of ways. 
Sample integration legitimation was ensured by having the same group of caregivers 
answering both the quantitative and qualitative aspects of the questionnaire, so that 
inferences could accurately be drawn from the data. Sequential legitimation was ensured, as 
the quantitative and qualitative questions were mixed together, which meant that the 
interpretations of the data were not affected by the sequence in which the qualitative and 













Table 2 describes the demographics of the sample. The majority of caregivers were literate, 
South African and English speaking.  
 
Table 2 
Demographics of caregivers  
                                                                                                                                      n (%) 
Literacy (N=59) 
 Literate                      55 (93.2)  
 Illiterate          4 (6.8) 
Nationality (N=59) 
 South African        40 (67.8) 
 Other         19 (32.2) 
Primary language (N =59) 
 English         28 (47.4) 
 French         11 (18.6)  
 Xhosa           9 (15.3) 
 Afrikaans          3 (5.1) 
Shona           3 (5.1) 
 French/ KiSwahili         1 (1.7)  
Ndebele          1 (1.7) 
KiSwahili          1 (1.7) 
Chichewa          1 (1.7) 
 German          1 (1.7) 
Number of children below 18 (N=59) 
 1 child         17 (28.8) 
 2 children        19 (32.2) 
 3 children        17 (28.8) 













3.1. Information provided to caregivers    
All seven of the pharmacists reported that labels are always included with OTC painkillers, 
with 90% of caregiver respondents reporting to always receiving labels with their OTC 
painkillers. Two of the pharmacists reported that medication inserts were never included 
with OTC painkillers given to patients (both of these pharmacists worked at government 
facilities which repackage tablet medication into small plastic packets (Figure 3), while five 
pharmacists reported that medication inserts were sometimes included with OTC painkillers. 
 
Figure 3  





The majority of the caregiver respondents (69.5%) reported to always receiving inserts 
(when buying painkillers packaged in a box) with 27% indicating sometimes receiving them 
and the remainder (3.4 %) reported to never receiving inserts with OTC painkillers. Four 
pharmacists reported to never providing PILs while three reported to sometimes providing 
PILs with OTC painkillers. Over half (61.0%) of the caregivers reported to never receiving 












receive PILs with OTC painkillers. Table 3 describes the information provided to caregivers 
by socioeconomic group.  The majority of respondents receive labels, while those in the high 
socioeconomic group receive inserts more often than those in the low socioeconomic 
group. There was a significant association between socioeconomic group and how often 
caregivers received medication inserts (p=0.000264) and PILs (p=0.006679). As expected, 
there was no significant association between socioeconomic status and how often 
caregivers received labels (p=0.663729). 
 
Table 3 
Caregivers access to OTC medication information by mechanism and socioeconomic group 
(N=59)  
           Always n(%)          Sometimes n(%)        Never n(%)                                                                                          
Label 
 High SE group                        28 (47.5)         2 (3.4)                 0 (0) 
 Low SE group            25 (42.4)         4 (6.8)                 0 (0) 
Medication Insert 
 High SE group            28 (47.5)          2 (3.4)                 0 (0) 
 Low SE group            13 (22.0)                       14 (23.7)                 2 (3.4) 
Patient Information Leaflet 
 High SE group             5  (8.5)                       2 (3.4)  23 (40.0)   













When asked whether the current verbal and written forms of information provided with 
OTC medication to caregivers were effective, 57% of the pharmacists felt that it was 
effective, while 43% felt it was ineffective. Table 4 illustrates the reasons provided for their 
perceived effectiveness or ineffectiveness. Based on their responses, pharmacists were 
divided in their opinions, with some suggesting that the information was effective as there is 
a large emphasis on providing counseling and parents can generally understand the 
information. Conversely, others felt it is ineffective as there is not enough time for 
counseling and the information is not sufficient for parents to understand. 
 
Table 4 
Pharmacists’ perceived effectiveness/ ineffectiveness of current verbal and written OTC 
information  
 
Reasons methods of communication are effective: 
 “Most patients have a degree of responsible and rational intellect” 
 “We take more time with parents and mothers” 
 “Now a days there is more and more emphasis on counselling and right outcome” 
 “Parents might not listen, but it is still up to the parent” 
Reasons methods of communication are ineffective: 
”Need lots of verbal communication between caregivers and patients in relationship 
of    trust” 
“Not enough info stuck on the actual bottle” 
“Not enough time with them” 
 
3.2. Consumption habits of different socioeconomic groups 
Most (95%) of respondents administered paracetamol to their children for a headache and/ 












painkiller for children, however the use of Ponstel™ (Mefenamic Acid (MA)), Ponstan™ (MA) 
and Calpol™ (Paracetamol) was only found in the higher socioeconomic group, as these are 
more expensive painkillers than paracetamol. Table 5 describes where individuals from each 
socioeconomic group obtain their OTC painkillers. 
 
Table 5 
Facilities where caregivers choose to obtain or purchase OTC medication by socioeconomic 
status group (N=59) 
                 Chemist (n=45)       Shop (n=11)         Clinic/ Physician (n=18)        Spaza Shop*(n=2)              
                                        n (%)                       n(%)                                 n(%)                                     n(%) 
High SES                      23 (40.0)               8 (13.6)                             6 (10.2)                0 (0) 
Low SES                       12 (20.3)               3 (5.1)                              12 (20.3)               2 (3.4) 
*Informal convenience shop business, usually run from home 
Some caregivers obtain painkillers from more than one facility                 
                                          
3.3. Sufficiency of information provided for dosing children  
Nearly half (48%) of the caregiver respondents did not have English or Afrikaans as their first 
language, but all respondents who were literate could read English. All of those who did not 
have English as their first language were in the lower socioeconomic status group. A small 
number (7%) were illiterate and unable to read the forms of information. Some (10%) of the 
respondents were unable to read the medication insert or the label (6.8%) because the print 
was too small for them to read (not because of language difficulties). All literate 
respondents could read the PIL.  A few respondents (10%) were unable to determine at 
what age a child could be given the paracetamol. When asked to provide the dosage, 10% 












3.4% reported an incorrect dosage (when reading the PIL). Three of the respondents 
reported that their child had become sick when taking OTC medication, specifically from 
paracetamol, however, according to the respondents, this was as a result of an allergic 
response to the paracetamol, as opposed to overdose. 
 
3.4. Ability of caregivers to use information as scientifically intended 
In testing respondents’ understanding of specific scientific terms found on all three 
mechanisms of information, 35% of caregivers indicated a lack of understanding and 38.8% 
answered one or more of the scientific terms incorrectly. A few caregivers (10%) 
acknowledged that they did not understand one or more specific scientific terms found in 
the label and on average, 11.9% answered the scientific terms incorrectly. Some (20%) 
acknowledged that they did not understand one or more specific scientific terms found in 
the PIL and on average, 16.4% answered the scientific terms incorrectly. More respondents 
found the insert difficult to understand with 32.2% answering the insert scientific terms 
incorrectly. Examples of scientific words in the PIL which were reported as difficult to 
understand or incorrectly interpreted included, ‘contraindication’, ‘side effect’, ‘ingredients’ 
and ‘exceed’.  The caregiver respondents found the following scientific words in the insert 
most difficult to understand, (in descending order of difficulty)  ‘overdosage’, ‘side effects’, 
‘interactions’, ‘pharmacological classification’, ‘composition’, ‘presentation’ and ‘dosage’. 
The majority of respondents seemed to understand the label’s dosage information while 
17% reported to finding the dosage instructions for children difficult to understand.  
3.5. Effectiveness of information in promoting informed decision making  
Caregiver respondents reported that the size of the text on the medication insert (70%), 











three forms of information was the easiest to read, 87% of the caregivers identified the PIL,
7% the label and 6% the medication insert. Many (60%) of the respondents thought that all
three mechanisms of information together provided adequate information to safely
administer it to their children. Reasons as to why caregivers felt the information usually
provided to them with OTC painkillers is sufficient or insufficient are described in table 6.
Reasons as to why the information is effective were not directly related to the information
provided but were attributed to other reasons such as trusting a health professional or
knowing it has worked in the past. Reasons as to why it was insufficient related more to the 
actual information, as caregivers found it difficult to understand.
Table 6
Caregivers’ reasons why the information provided by all three mechanisms of information is
sufficient/ insufficient
Reasons why information is sufficient
“Because I know”,
“It has worked in the past” and
“I trust health professionals giving it to me”.
Reasons why information is insufficient 
 “It doesn’t tell you what the medication does in the body, but sometimes it does, but it’s 
scientific so I don’t understand it. And if there are warnings, they are in small writing or in 
the last section of the page…there are never clear warning signs”   
“It is ambiguous and difficult to read, not in lay man’s terms…the writing is so small so I just 
tend to glance over it. 
3.6. Respondent recommendations for improvement of information 
Caregivers suggested that the important sections, for example dosage, be printed in larger 











the important information quickly. Both caregivers and pharmacists suggested the use of
pictograms or diagrams to assist those who are unable to read or understand the 
information. Both groups suggested that simpler words be used or that a glossary of
scientific terms could be provided for those who wish to use them as a reference. Most
caregivers would like information about dosage for children to be more explicit (as the 
dosage is often clearer for adults than children) as well as potential side effects to be 
written in layman’s language on the label. Some caregivers suggested that there be more
information about what to do in the event of overdose as well as contact details for the 
closest Poison Centre.
4. Discussion & Conclusion
4.1. Discussion 
In order for individuals to make informed decisions about dosage and risk, it is imperative
that the information is written at the correct literacy level for readers with varied levels of
health literacy. In a United States study, half of adults were not able to understand basic
health information, despite having adequate levels of literacy (35). This was highlighted in
this study, in that many of the caregivers were able to read the information provided, but
were not able to understand it enough to make decisions about dosage requirements for
their children, which was also found in the Clamusa et al. study among Italian OTC
medication users (1). An interesting finding was that respondents found the scientific words
in the label easier to understand than the PIL, yet the purpose of the PIL is to provide
information which the end user can easily understand. This could be due to the label using
fewer words than the PIL, resulting in the respondents needing to understand fewer terms.











as understanding the interactions of the drug, which again, were also found in the Italian
study (1). As highlighted in the factors needed for effective risk communication (30), many
caregivers found the inconsistency of the dosage between the three pieces of information
confusing (explicit dosage instructions for children were found on the PIL and insert but not
the label, which just mentioned adult dosage). This made them question the intensity of the
drug, as an inconsistent dosage did not communicate a high risk of danger if overdosed. This
highlights how the content of the information is much more important than the quantity of
information, as those who are most in need of information, will not necessarily read or
understand all of the information provided, unless it is appropriate for their level of
understanding.
It is important to note that the majority of the respondents found the PIL easiest to 
understand and calculate dosages correctly, making it the most effective mechanism of
information in this study, but that this same majority had never even seen or heard of a PIL 
before. PILs are not commonly provided with OTC medications in South Africa, however if
they were, more end users could effectively access health information. This is despite a
large proportion of caregivers obtaining their OTC painkillers from private pharmacists, who
should be providing PILs with the medication. This is further highlighted by the researcher
not being able to find a PIL in packaged paracetamol to collect data for this study. Lack of
provision of PILs is due to the pharmaceutical companies not providing them in the
packaging, or due to pharmacists having limited capacity to make copies of them for
distribution with repackaged medication. However, legislation states that all medicines
distributed in South Africa should be provided with PILs, which requires pharmaceutical











checking the content of PILs, the Medicine Council should also be ensuring more compliance 
with legislation by checking that PILs are actually being distributed. Most of the pharmacist 
respondents reported that according to their knowledge, the purpose of the medication 
insert is for use by health professionals, whereas the PIL is intended for the public. Perhaps 
it would then be more beneficial to the OTC users (and cost effective for the provider) if 
companies provided a label and simple PIL instead of a medication insert, with references 
provided to health professionals if further scientific information is needed.   
All seven pharmacists interviewed emphasized the importance of providing verbal
information or ‘counselling’ to each patient. However, accessing information from health
professionals does prove to be difficult in a South African context, due to the presence of
language barriers and patients not feeling comfortable to ask questions or clarify
information about their medication (36). Within many health facilities, health professionals
often only fluently speak English and Afrikaans, without having sufficient communication
skills in any of the other nine official African languages or with limited access to interpreters.
In this study, there was a significant discrepancy between socioeconomic groups, as those in
the lower socioeconomic group generally had less access to written mechanisms of
information accompanying their OTC medication. However, it was found that some 
caregivers in the lower socioeconomic status group were unaware that they even had a
right to receive more information, reporting that they were content with the amount of
information given. Reasons for this included, ‘it is given by a doctor who knows the 
medication and problem’ and ‘if somebody gives you the tablets they will give you all the 
information and the information is enough’. This further emphasizes the importance of











professional that they seem to inherently trust, which according to risk communication 
theory, is effective in conveying risk (30). However, conversely, it is difficult to in control the 
content and consistency of verbal information provided to users in different settings, leaving 
potential for inconsistencies and ineffective communication of important health 
information. 
Although information is provided for free with all OTC painkillers, there was a difference in
what information was provided in different locations. The reality is that those obtaining OTC
medication (and information) from public institutions will usually only be provided with a 
label (as seen in the results of this study) or plastic bag with limited written instructions, and
are usually provided with less verbal counselling due to limited time and increased
pressures to tend to many patients. Those obtaining OTC medication from private 
pharmacies or general stores will usually be provided with some information (such as the
insert) along with the label, and may be able to ask more questions to the pharmacist on
duty. As the majority of those with basic literacy levels (according to level of education)
were in the lower socioeconomic status group, they would tend to be the group obtaining
their OTC medication from government facilities. As pharmacists tended to suggest that the
information was effective because most patients have sufficient ‘intellect’ or ineffective due
to their being limited time, this also shows that the information being provided to those in
the lower socioeconomic groups is also less effective. This is something which is also seen in
the rest of the South African health system, where the educated who have resources to
afford quality health care, do receive it, while the less educated continue to have poor












4.2. Strengths and Limitations 
There were a number of limitations in this study. Due to the nature of the study design,
there was potential for both selection and information biases during the data collection
process. Selection biases include the potential for the hawthorne effect, sample bias and
participation bias. Recall bias could also be a specific form of information bias present in the 
study. Using a cross sectional study design could result in difficulties with drawing
conclusions that are representative of the whole population. Budget and time constraints
limited the size, and therefore could affect the precision of the quantitative findings. A 
strength of the study included having caregivers from a variety of backgrounds and
investigator triangulation in the analysis of the findings. Having one researcher and one
measure (questionnaire) in the study ensured internal validity of the findings.
4.3. Conclusion 
This study highlights some of the major challenges for health providers and policy makers to
prevent caregivers from overdosing their children with common painkillers. Firstly, many
people do not have access to enough information to make informed decisions about
administering medication to their children. Those who are provided with sufficient
information are usually the patients who are educated and also have adequate levels of
health literacy to make informed decisions with the information provided. It is, therefore,
imperative that packages have at least one of the three legislated mechanisms of
information (preferably the PIL) in order to increase information provision to lower-
socioeconomic populations. Secondly, even when those in need of information are provided
with this information, this information is usually limited, not appropriate or not understood. 











overdosing on OTC painkillers with children, their lack of understanding and low perceived 
risk of this medication potentially places their children at risk of being overdosed with OTC 
painkillers, and that overdosing may not be understood.  
4.4. Practice Implications 
Suggestions for improved practice include providing pictograms to convey important
concepts such as dosage and warnings, and use of a glossary to provide further explanation
of scientific terms in simpler words, in a variety of languages. Pharmaceutical companies
and government need to acknowledge the growing refugee communities in low and middle 
income countries such as South Africa and therefore the need for information in French, for
example, PILs. According to legislation, the actual information itself should be reviewed the
Medicines Control Council to adequately address the health literacy levels of end users, with
there being more emphasis on providing PILs. This includes simple terms or pictures which
are easily understood by the lay person, with a clear, simple design. Spot checks of
pharmaceutical providers could be done to ensure compliance of PIL provision. The 
responsibility lies with pharmacists to provide as much verbal counselling as possible, and
with the adult caregiver, to make use of their right to access to information to avoid
overdosing of children with painkiller OTC medication. As this study focused on
paracetamol, which comes with a label and insert, more research is needed focusing on
other OTC painkillers. Especially those OTC painkillers provided through more informal
means, for example, by pharmacists who provide repackaged medication in small plastic
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Respondent No: _____________________________________________________________ 
Date of interview: ____________________________________________________________ 
Place of interview: ___________________________________________________________ 
Date of Birth: _______________________________________________________________   
Gender (please tick):     Male ________________________ Female_____________________ 
Home language: _____________________________________________________________ 
Home address: ______________________________________________________________ 
Highest level of education:___________________________________________________________ 
Occupation (if applicable): _____________________________________________________ 
Partner’s occupation (if applicable): ______________________________________________ 
Annual income: _____________________________________________ 
Number of children: __________________________________________________________ 




A. 1) If your child has a headache and fever, would you give him/ her medication?
yes no 
A. 2) If yes, what medication would you give your child?
___________________________________________________________________________
A. 3) Do you give any of the following medicines to your children?
Ponstel Yes no 
Stopayne Yes no 
Stilpane Yes no 
Paracetamol Yes no 
Disprin Yes no 
Other (please state) Yes no 
B. 1) Where do you usually get painkillers for your children?
___________________________________________________________________________ 
B.2) Why do you get them there?
___________________________________________________________________________ 
B. 3) Do you have to pay for these painkillers?











B. 4) Does the medication come with packaging (e.g. in a box) or in a packet provided by the pharmacy/ store? 
sometimes never always 
B. 5) If you got your painkillers from a private pharmacist/ chemist in the last year, did the pharmacist tell you
verbally how to correctly give the medication to children? (choose one) 
yes no N/A Can’t remember 
B.6) If yes, what did he/ she tell you about the medication? 
Can’t remember Did not give info N/A 
B. 7) Did the pharmacist give you any written information about the correct use of medication with children?
(choose one) 
yes no N/A Can’t remember 
B. 8) If yes, did you read the information given? 
yes no Did not give information N/A Can’t remember 
B. 9) If you did read it, what information can you remember most?
Can’t remember Did not read info N/A 
B. 10) If you got your painkillers from a clinic in the last year, did the pharmacist tell you verbally how to
correctly give the medication to children? (choose one)
yes no N/A Can’t remember 
B. 11) If yes, what did he/ she tell you about the medication?
Can’t remember Did not give info N/A 
B. 12) Did the pharmacist at the clinic give you any written information about the correct use of medication
with children? (choose one) 
yes no N/A Can’t remember 
B. 13) If yes, did you read the information given?
yes no Did not give information N/A Can’t remember 
B. 14) If you did read it, what was included in the information?











B. 15) If you have purchased painkillers from a shop e.g. Pick n’ Pay/ Clicks or Spaza shop, did you ask anyone
for more information about the safe use of painkillers with children? 
yes no 
B. 16) If you did ask for more information, who did you ask? (please tick)
The employee working at the till      
The shop’s information desk 
A family member 
A friend 
The internet 
I did not ask anyone for more information 
B. 17) Do the painkillers that you buy come with the following? (show documents)
A label 
A medication insert 
A Patient Information leaflet 
sometimes never always 
C. 1) You reported that you give _____________________ (A.2 answer) when your child has pain or fever.
What were your reasons for choosing this medication?
___________________________________________________________________________
C. 2) Did you hear about the medication from any of the following sources?
Friend Family Billboard/ Sign Television Health Professional 
C. 3) How much of the medication do you buy at one time?
___________________________________________________________________________
C. 4) Where do you store your over-the-counter medication at home?
___________________________________________________________________________ 
C. 5) At what age do you let your children help themselves to this medication when they are sick?
___________________________________________________________________________ 
C.6) Would you allow the following people to give medication to your child if you are not able to give it to 
them? (Please tick) 
Your partner yes no Why? 
Your other children yes no Why? 
A neighbour yes no Why? 
A friend yes no Why? 












Another family member yes no Why? 
 
D. 1) How often do you read the information on the Medication Insert (if given) before giving the medication 
to your child?  
sometimes always never not given 
 
D. 2) If not, why not?  
 N/A 
D. 3) Are there specific sections that you always read? Please state   
 N/A 
 
D. 4) Are there any sections that you ignore? Please state  
 N/A 
 
Please read the Panado™ medication insert and answer the following questions: 
Participant is unable to read information insert due to:  
inadequate literacy 
levels 
Insert not written in language participant reads (language____________) N/A 
 
D. 5) At what age is it safe to give a child this medication?  
_______________________________________________________________________________ 
D. 6) How much can the child be given at one time?  
_______________________________________________________________________________ 
D. 7) After giving a child Panado™, do you have to wait before you give more Panado™? 
yes no 
 
D. 8) If yes, how long do you have to wait? 
____________________________________________________________________________ 
D. 9) How many times in one day can you give this medication to a child ?  
____________________________________________________________________________ 
D. 10) What is the maximum amount of Panado™ a child is allowed in one day?  
_______________________________________________________________________ 
D. 11) Do you think your child could be poisoned from taking too much of the medication?  
yes no 
 












D. 13) After how many days of taking this medication should you call a doctor if your child’s health is not
improving?  
__________________________________________________________________________ 
D. 14) Can this medication cause your child to have:
Skin rashes Yes No 
Vomiting Yes No 
Diarrhoea Yes No 
D. 15) List one more side effect that this medication could cause your child to have.
_________________________________________________________________________ 
D. 16) What does the word ‘contraindication’ mean?
__________________________________________________________________________ 
D. 17) What does the word ‘overdosage’ mean? 
__________________________________________________________________________
D. 18) What does the word ‘hypersensitivity’ mean?
__________________________________________________________________________
D. 19) What is this medication for? 
sore throat Yes No 
allergies Yes No 
vomiting Yes No 
headache Yes No 
D. 20) Indicate which part of the medication insert you find most difficult to understand
__________________________________________________________________________ 
D.21) What do you think about the size of the writing on the page?
Too big Too small Correct size 
D. 22) Do you think there is any information missing from this medication insert?
Yes no 
D. 23) If yes, what do you think should be added to the information already given? 
N/A 
E. 1) How often do you read the information on the Medication label (if given) before giving the medication to
your child? 











E. 2) If not, why not?
N/A 
Please read the Panado™ label (on the box) and answer the following questions: 
Participant is unable to read label due to:  
inadequate literacy 
levels 
Label not written in language participant reads 
(language____________) 
N/A 
E. 3) Is it safe to give this medication to a child under the age of 6 years?
yes no 
E. 4) How much can a child (age 6-12 years) be given at one time? 
___________________________________________________________________________
E. 5) After giving a child Panado™, do you have to wait before you give more Panado™?
yes no 
E.6) If yes, how long do you have to wait?
____________________________________________________________________________ 
E. 7) How many times in one day can you give this medication to a child (age 6-12 years)?
___________________________________________________________________________
E. 8) What is the maximum amount of Panado™ a child (age 6-12 years) is allowed in one day?
_______________________________________________________________________
E.9) After how many days of taking this medication should you call a doctor if your child’s health is not
improving?
__________________________________________________________________________
E.10 ) What does the word ‘mild’ mean?
__________________________________________________________________________ 
E.11 ) What does the word ‘continuously’ mean?
__________________________________________________________________________ 
E. 12) Indicate which part of the medication label (on the box) you find most difficult to understand
__________________________________________________________________________ 
E. 13) What do you think about the size of the writing on the box?
Too big Too small Correct size 
E. 14) Do you think there is any information missing from the label?
yes no 












F. 1) How often do you read the information on the Patient Information leaflet (if given) before giving the
medication to your child? 
sometimes always never Medicines not given with PIL 
F. 2) If not, why not?
N/A 
Please read the Paracetamol Patient Information Leaflet and answer the following questions: 
Participant is unable to read PIL due to:  
inadequate literacy 
levels 
PIL not written in language participant reads 
(language____________) 
N/A 
F. 3) At what age is it safe to give this medication to a child?
__________________________________________________________________________________
F. 4) How much can the child be given at one time?
_________________________________________________________________________________
F. 5) After giving a child Panado™, do you have to wait before you give more Panado™?
yes no 
F. 6) If yes, how long do you have to wait?
____________________________________________________________________________
F. 7) How many times in one day can you give this medication to a child? 
_________________________________________________________________________________
F. 8) What is the most amount of Panado™ a child can take in one day?
_______________________________________________________________________ 
F. 9) Is it safe to take the medication when you are breastfeeding? 
yes no 
F. 10) After how many days of taking this medication should you call a doctor if your child’s health is not
improving?  
__________________________________________________________________________ 
F. 11) Can this medication cause your child to have:
Skin rashes Yes No 
Vomiting Yes No 











F.12) List one more side effect that this medication could cause your child to have.
__________________________________________________________________________ 
F. 13) What does the word ‘exceed’ mean?
__________________________________________________________________________ 
F. 14) What does the term ‘side effect’ mean?
__________________________________________________________________________ 
F. 15) What the word ‘allergic’ mean?
__________________________________________________________________________ 
F. 16) What is this medication for?
headache Yes No 
Tooth ache Yes No 
dizziness Yes No 
body pain yes No 
F. 17) Indicate which part of the PIL you find most difficult to understand
__________________________________________________________________________
F. 18) What do you think about the size of the writing on the page? 
Too big Too small Correct size
F. 19) Do you think there is any information missing from the PIL?
yes no 
F. 20) If yes, what do you think should be added to the information already given?
N/A 
G. 1) Have you ever had to take your child to the doctor/ clinic/ hospital because your child became sick after
taking the medication you gave him/ her? 
yes no 
G. 2) If yes, what medication did he/she take?
N/A 
H. 1) Which form of information (PIL, medication insert or label) do you find easiest to read?
label PIL Medication insert 
H. 2) Do you think that the current information provided with medication gives you enough information about














H. 4) From which sources would you like more information about the dosage requirements and risks of over-
the-counter medication?  
Written information with medication yes no 
Pharmacist yes no 
advertising yes no 
Friends and family yes no 
H. 5) Would you find the information easier to understand if it was written in another language other than
English/ Afrikaans? 
Yes No 
H. 6) If your child developed an allergic reaction after taking the medication what would you do?
___________________________________________________________________________
















Respondent No:  
Date of interview:  
Place of interview: 
Demographic Information: 
A.1) Date of Birth:
A.2) Gender (please tick):
Male Female 
A.3) Home language:
A.4) Type of Facility (please tick)
Public Private General store 
A.5) Degree/ highest level of training:
A.6) Position (e.g. Pharmacist, Head of Dept, etc)
A.7) Pharmacy location
A. 8) How long have you worked at this pharmacy?
Questions: 
COMMON PAINKILLERS 
B.1) What are the most common over-the-counter painkiller medications sold/ administered in your
dispensary to those in higher socioeconomic groups? (please list top 3)
B. 2) What are the most common over-the-counter painkiller medications sold/ administered in your
dispensary to those in lower socioeconomic groups? (please list top 3)
B. 3) What is the most common over-the-counter medication that you recommend for people from a higher
socio-economic group: 
Children with a fever?  
Children with a headache?  
B. 4) What is the most common over-the-counter medication that you recommend for people from a lower
socio-economic group: 
Children with a fever?  
Children with a headache? 













C.1) Are the following generics sold in re-packaged containers/ packets to the general public from this
pharmacy? (please tick)  
Paracetamol Yes No 
Aspirin Yes No 
Ibuprofen Yes No 
If you answered yes please answer the following questions: 








C. 4) Are medical medication inserts included with the re-packaged medication? (please tick)
Paracetamol Yes No 
Aspirin Yes No 
Ibuprofen Yes No 
C.5) Which socioeconomic group commonly buys re-packaged generics?
Higher socioeconomic Lower socioeconomic Both groups 
C.6) Are Patient Information Leaflets included with the re-packaged medication? (please tick)
yes no 
C.7) How are they included?
C.8)  What do you do if a person asks for more information regarding medication?
INFORMATION PROVISION 
D.1) What information do you believe is required to be included with all over-the-counter medication when















D. 4) Do you provide different information to clients buying/ obtaining medication for their children compared
to the information given to other groups of consumers? 
Yes no 
D.5) Why? 
D. 6) Please describe what you understand the following forms of information to be:
Medication label 
Medication insert 
Patient information leaflet 
D.7) When distributing to clients/ consumers, are labels provided with all OTC medicines?
Always never sometimes 
D.8) When distributing to clients/ consumers, are medication inserts provided with all OTC medicines?
Always never sometimes
D.9) When distributing to clients/ consumers, are Patient information leaflets provided with all OTC
medicines? 
Always never sometimes 
D.10) Do you think the following forms of information are effective in communicating health risks and dosage
requirements to clients? 
Medication labels yes no 
D.11) Why?
D.12)













Patient information leaflets yes no 
D.15) Why?
D.16) Do pharmacy assistants provide information to clients when selling/ providing OTC medicines?
Yes no 
D.17) When are they expected to provide information to clients regarding OTC medicines?
D.18) Do pharmacy assistants and pharmacists provide the same information with OTC medication?
Yes no 
D.19) If no, how does it differ?
N/A 
D.20) What do you consider to be common problems experienced by clients when they administer OTC
medication? 
D.21) Do you think there is sufficient information provided with OTC medication to assist with these problems?
D.22) Do you think that overdosing of children with OTC medication is a problem?
Yes no 
D.23) Why?
D.24) Do certain groups tend to ask for more information about OTC medicines than other groups?
Always sometimes never 
D. 25) If yes, which groups tend to ask for more information?
MEDICATION INFORMATION 
Please read the accompanying medication insert and answer the following questions: 
E.1) Is it safe to give pain medication to children of the following ages?
0 – 3 months yes no 











1 year – 6 years yes no 
E.2) If yes, how much can the child be given at one time?
0 – 3 months N/A 
3 months – 1 year N/A 
1 year – 6 years N/A 
6 years – 12years N/A 
E.3) How many times in one day can one give the medication to a child (aged 6-12 years)? 
E.4) What is the maximum amount of pain medication a child (aged 6-12 years) is allowed in one day?
E.5) What does the word ‘contraindication’ mean?
E. 6) What does the term ‘hepatic function’ mean?
E. 7) What does the word ‘cardiovascular’ mean? 
E.8) Are the following reported to be side effects of this medication?:
Skin rashes Yes No 
Vomiting Yes No 
Diarrhoea yes No 
E.9) How often have customers reported to you in the last year that their child experienced side effects from
the OTC medication they administered to their child?
Never Less than 5 times More than 5 times 
E.10) If they do report side effects, what are the side effects reported?
E.11) What is your opinion of the size of the writing in medication inserts?
E. 12) What is your opinion of the design of medication inserts?
LANGUAGE 
F.1) How do you communicate information regarding safe use of over-the-counter medication to your
customers/ patients if they speak a different language to you? 













F.4) Do you find it difficult to explain any definitions or terms found on medication labels or leaflets to 
patients/ customers? 
Yes no 
F.5) If yes, please describe which definitions or terms you find difficult to explain
F.6) From your experience, do you think that the general population is fully informed and aware of the risks
regarding over-the-counter painkiller use? (please tick) 
yes no 
F.7) Why do you think that they are/ are not fully informed or aware of the risks regarding over-the-counter
medication use? 
F.8) Do you think the current way of communicating risks to caregivers is adequate enough to enable safe
administration of OTC medication in children? 
Yes no 
F.9) Can you elaborate why or why not?
RECOMMENDATIONS 
G.1) What recommendations do you suggest for making medication users more aware of the risks of over-the-
counter medication, especially for low literate populations and populations who do not speak/read English and
Afrikaans?
G. 2) What recommendations do you suggest for making medication users more aware of the dosing
requirements of over-the-counter medication, especially for low literate populations and populations who do 
not speak/read English and Afrikaans? 
G.3) Are there forms of communication other than labels, medication inserts or PIL’s that you would
recommend using for making medication users more aware of the risks of OTC medication? 
Yes no 












G.5) Do you have any suggestions for improving the layout and design of the PILs, inserts and labels?
Yes no 
G.6) If yes, what are they?
N/A 
G.7) Is there any information that should be omitted from the medication inserts to encourage safer use of
OTC medication? 
Yes no 
G.8) If yes, what should be omitted?
N/A 
G.9) Is there any information that should be added to the medication inserts to encourage safer use of OTC
medication? 
Yes no 
G.10) If yes, what should be added? 
N/A 





G.12) Do you feel this training is sufficient?
Yes no 
G.13) If no, how do you suggest it could be improved?
N/A 











3. Informed consent (Caregiver)
Research Title 
“But it’s just Paracetamol”: Caregivers’ ability to make informed decisions about 
administering over-the-counter painkillers to their children with the information provided 
Introduction 
My name is Fiona Gibson and I am a Masters of Public Health student at the University of 
Cape Town Working on my thesis. You are kindly invited to take part in our research study 
and we would like to ask for your permission to be included in the study. Please read the 
information below and let me know if you need any clarifications or have any concerns. 
Background and reason for the study: 
The purpose of this study is to find out if you have been given enough information about
common painkillers when you have gotten them from the clinic or the shop, and if this
information helps you to safely give the right amount of medication to your child, at the
right times. We would also like to find out how well you understand the instructions given
to you and if there is anything we can recommend to the pharmaceutical companies to
make the information easier to understand. Your participation in the study will therefore 
assist us in improving the information provided with medicines.
What will be required of you should you choose to be a part of the study?
You have been chosen to participate in the study because you are a caregiver who attends a 
group or clinic at Jubilee Community Church. If you choose to take part in the study, you will
be asked to answer a few questions in a questionnaire, which will include details such as
where you live and your level of schooling, as well as other questions such as what kind of
medication do you give your child or whether you are aware of the risks of the medication.











What are the benefits of participating in the study? 
There are no major individual benefits of participating in the study; however, an information 
leaflet about how to safely use over-the-counter medication will be given to you, which 
could be beneficial for the health of your child in the future.  
The group that you attend will be given a gift to thank you for your time given to participate 
in the study. On a larger scale, the researcher is hoping to publish the findings so that others 
in the medical profession can understand more about what information is needed for 
caregivers when they are providing medication to their children.  
What are the risks of participating in the study?
The investigator is not aware of any risks of participating in the study.
What if you agree to participate in the study and then decide that you do not want to
continue being a part of it?
You are completely free to stop participating in the study at any time. This means that if you
are in the middle of completing the questionnaire, you will not be forced to answer any
questions that you are not comfortable to finish or if you have completed the questionnaire
and wish for your answers to be taken out of the study, please feel free to contact the
investigator. For any questions or comments, you can contact the investigator on the 
following number or email address:
Name: Fiona Gibson 
Tel: 0741714014 
Email: gibson.fa@gmail.com 
If you would like to contact the board of ethics with any questions or concerns please feel 
free to contact them. There contact details are available here: 
Research Office at the University of Cape Town Faculty of Health Sciences 











Confidentiality and anonymity  
All questionnaires will be kept in a secure area and all information will remain confidential 
i.e. the investigator will not discuss or reveal any of your personal information or answers
with anyone in the group or anyone else not involved with the study. All questionnaires will 
be completely anonymous i.e. the identity of who filled in each questionnaire will not be 
known by the investigator or the public. I will also not mention that the study was done in 
Jubilee Church so that no one knows that the study was done here. 




This consent form has been clearly explained to me, all of my questions have been clearly
answered and I understand all of its contents. I understand that my participation in the 
study is voluntary. I understand that I do not have to answer any question that I feel
uncomfortable answering and am free to withdraw from the study at any time, without
anyone asking my reasons for leaving. I know that I can contact the researchers if I have any
questions about the study, or if I would like to withdraw from the study. I understand that
all information will remain confidential and anonymous.
I give consent to participate in this study.
Name and Signature (Participant): 
Date:  
Investigator 
I declare that this document was thoroughly explained to the participant and all questions 
were answered in full.  












4. Informed consent (Pharmacist)
Research Title 
“But it’s just Paracetamol”: Caregivers’ ability to make informed decisions about 
administering over-the-counter painkillers to their children with the information provided 
Introduction 
My name is Fiona Gibson and I am a Masters of Public Health student at the University of 
Cape Town Working on my thesis. You are kindly invited to take part in our research study 
and we would like to ask for your permission to be included in the study. Please read the 
information below and let me know if you need any clarifications or have any concerns. 
Background and reason for the study: 
The purpose of this study is to find out where caregivers obtain their medication from and
what type of medication they commonly use. We would also like to determine whether
caregivers have enough information about common painkillers when they have obtained
them from the clinic or the shop, and if this information helps them to safely give the right
amount of medication to their child, at the right times. We would also like to find out how
well they understand the instructions given to them and if there is anything we can
recommend to the pharmaceutical companies to make the information easier to
understand. Your participation in the study will therefore assist us in improving the 
information provided with medicines.
What will be required of you should you choose to be a part of the study? 
You have been chosen to participate in the study because you are a representative of a 
pharmaceutical service provider commonly used by caregivers in our study. If you choose to 
take part in the study, you will be asked to answer a few questions in a questionnaire, which 
will include details such as your position and level of training, as well as other questions 
such as what kind of medication do you provide to caregivers and what type of information 
is given with over-the-counter medication. The questionnaire should take approximately 15 











What are the benefits of participating in the study? 
There are no major individual benefits of participating in the study; however, a journal 
article detailing the findings of the study as well as any further recommendations for 
pharmacists will be sent to you via post. On a larger scale, the investigator is attempting to 
provide more research on this topic which can potentially be used to inform policy makers 
of what information is needed for caregivers when they are providing medication to their 
children.  
What are the risks of participating in the study? 
The investigator is not aware of any risks of participating in the study. The questionnaire
may require you to be away from work tasks for approximately 15 minutes, however your
work schedule will be accommodated and the investigator will only administer the
questionnaire at your convenience.
What if you agree to participate in the study and then decide that you do not want to
continue being a part of it?
You are completely free to discontinue participating in the study at any time. This means
that if you are in the middle of completing the questionnaire, you are also not obligated to
answer any questions that you are not comfortable to finish or if you have completed the
questionnaire and wish for your answers to be taken out of the study, please feel free to
contact the investigator. For any questions or comments, you can contact the investigator
on the following number or email address:
Name: Fiona Gibson 
Tel: 0741714014 
Email: gibson.fa@gmail.com 
If you would like to contact the board of ethics with any questions or concerns please feel 
free to contact them. These are their contact details: Research Office at the University of 
Cape Town Faculty of Health Sciences 











Confidentiality and anonymity  
All questionnaires will be kept in a secure area and all information will remain confidential 
i.e. the investigator will not discuss or reveal any of your personal information or answers
with anyone not working on the study. All questionnaires will be completely anonymous i.e. 
the identity of who filled in each questionnaire will not be known by the investigator, your 
employer or the public, and your facility will also remain unnamed. Individuals outside of 
the study will only know whether your facility is in the private or public sector. Participating 
in this study will not influence your work in any way and no information given in the 
questionnaire will be given to your employer or employees.  




This consent form has been clearly explained to me, all of my questions have been
answered and I understand all of its contents. I understand that my participation in the 
study is voluntary. I understand that I do not have to answer any question that I feel
uncomfortable answering and am free to withdraw from the study throughout the whole
research process. I know that I can contact the researchers if I have any questions about the 
study, or if I would like to withdraw from the study. I understand that all information will
remain confidential and anonymous.
I give consent to participate in this study.
Name and Signature (Participant):  Date: 
Investigator 
I declare that this document was thoroughly explained to the participant and all questions 
were answered in full.  
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Patient Education and Counseling is an interdisciplinary, international journal for patient
education and health promotion researchers, managers, physicians, nurses and other health
care providers. The journal seeks to explore and elucidate educational, counseling and
communication models in health care. Its aim is to provide a forum for fundamental as well
as applied research, and to promote the study of the delivery of patient education,
counseling, and health promotion services, including training models and organizational
issues in improving communication between providers and patients.
Patient Education and Counseling is the official journal of the European Association for
Communication in Healthcare (EACH) and the American Academy on Communication in
Healthcare (AACH).
Definitions
Patient education is defined as a planned learning experience using a combination of
methods such as teaching, counseling, and behavior modification techniques which
influence patients' knowledge and health and illness behavior. Patient counseling is an
individualized process involving guidance and collaborative problem-solving to help the 
patient to better manage the health problem. Patient education and counseling involve an
interactive process which assists patients to participate actively in their health care. Clinical
health promotion is a part of the patient education and counseling defined as that which
predisposes, enables, and reinforces patients to take greater control of the non-medical
determinants of their own health.
Submission of Manuscripts 
The journal welcomes unsolicited manuscripts related to the field of patient education, 
counseling, clinical health promotion and communication in health care. 
Patient Education and Counseling uses an online, electronic submission system. By accessing 
the website http://ees.elsevier.com/pec you will be guided stepwise through the creation 











System, authors need to provide an electronic version of their manuscript. Authors may 
send queries concerning the submission process, manuscript status, or journal procedures 
to the Editorial Office. Once the uploading is done, the system automatically generates an 
electronic (PDF) proof, which is then used for reviewing. All correspondence, including the 
Editor's decision and request for revisions, will be by e-mail. 
Manuscript Categories 
During online submission, the author can select a category from the following list: Review, 
Original Article, Educational or Counseling Model, Short Communication, Book Review or 
Letter to the Editor, Reflective practice or Medical Education. The type of manuscript should 
be indicated in the cover letter. 
Original Articles - Preference is given to empirical research which examines such topics as
adherence to therapeutic regimens, provider-patient communicati n, patient participation
in health care, degree of social support, decision-making skills, anxiety, physiological
changes, or health/functional status (maximum 4000 words not including references and
tables). Both descriptive and intervention studies are acceptable.
Review Articles (Current Perspectives) - In-depth reviews of the empirical research in one 
facet of the patient education and counseling including an analytical discussion of
contemporary issues and controversies in patient education and counseling (maximum 5000
words not including references and tables).
Educational Model of Health Care - Case studies of innovative programs which exemplify
the educational model of health care, for example, self-care groups, patient advocacy
efforts, medication self administration programs and co-operative care units (maximum 
2000 words not including references and tables).
Short Communications in any of the above categories will also be considered (maximum
1500 words not including references and tables).
Reflective practice - The Reflective Practice section includes papers about personal or
professional experiences that provide a lesson applicable to caring, humanism, and
relationship in health care. We welcome unsolicited manuscripts. No abstract is needed. No
(section) headings, no numbering. Maximum 1500 words. First name and surname of the 











address where the corresponding author can be contacted, title of the papers and text. 
Submissions will be peer-reviewed by two reviewers. 
All authors must include one of these two statements at the end of their manuscript: 
(1)" I confirm all patient/personal identifiers have been removed or disguised so the 
patient/person(s) described are not identifiable and cannot be identified through the details 
of the story." 
OR 
(2) " I confirm that the patient/person(s) have read this manuscript and given their
permission for it to be published in PEC". 
For further information on the Reflective Practice section see: Hatem D, Rider EA. Sharing 
stories: narrative medicine in an evidence-based world. Patient Education and 
Counseling 2004; 54:251-253. 
Medical Education - Articles on medical education focus on educational efforts that target
experiences, programmes and educational research on the teaching/training and evaluation
of interpersonal/communication skills of health care providers and their attitudes and skills
needed for optimal communication.
Manuscript Organization 
Manuscripts should be organized as follows:
Title page, Abstract, 1. Introduction, 2. Methods, 3. Results, 4. Discussion and Conclusion, 
References, Legends.
Keep text, graphics and tables as separate files - do not import the figures and tables into
the text file. Tables and Figures should be uploaded as separate table files and separate 
figure files. Acknowledgments for technical assistance should be indicated on the title page.
Financial Support and any conflict of interest should be indicated in the acknowledgments.
All articles and reviews must have a structured abstract not exceeding 150-200 words and
appropriate keywords. Abstracts should adhere to the following format: Objective, 
Methods, Results, Conclusion, Practice Implications.











The title page should include a concise and informative title, first name and surname of the 
first author and his/her institution affiliation address. Please also provide an address, 
telephone and fax number and e-mail address where the corresponding author can be 
contacted. For co-authors, mention only first name and surname of their institution 
affiliation, but no address. 
Footnotes to the text should be avoided. 
Discussion and Conclusion should be headed as one section and divided into three parts. 
Example: 4. Discussion and Conclusion, 4.1. Discussion, 4.2. Conclusion. 4.3 Practice 
Implications 
Practice Implications
Articles should include a paragraph or paragraphs entitled 'Practice Implications' as part of
the discussion and conclusion, which outlines the implications for practice suggested by the 
study. Authors should take care that these implications follow closely from the data 
presented, rather than from other literature. In the event that an article presents very
preliminary data or conclusions, these paragraphs may be omitted.
References
Reference citations should be numbered consecutively throughout using Arabic numerals in
parentheses or square brackets (not superscripts). References should be double-spaced and
start on a separate page. References should conform to the system used in Uniform 
Requirements for Manuscripts Submitted to Biomedical Journals (Brit Med J 1991;302:338-
41; N Engl J Med 1991;324:424-8), using standard abbreviations of the journal titles cited in
Current Contents.
[1] Rosenberg SG. Patient education leads to better care for heart patients. HWHA Health
Rep 1971;86:793-802. 
[2] Worden JW. Grief counseling and grief therapy: a handbook for the mental health
practitioner. New York City: Springer, 1982. 
[3] Greenfield S, Kaplan S, Ware JE. Expanding patient involvement in care: effects on
patient outcomes. Ann Intern Med 1985;102:520-8. 











theoretical approaches and a new model. In: Schwarzer R, ed. Self efficacy: thought control 
of action. Washington, DC: Hemisphere, 1992;217-42. 
Note All authors' names should be listed. Issue numbers should not be included. 
Headings 
Headings should be arranged in hierarchically manner according to the following plan: 
- first level, numbered 1., 2., etc., first letter capitalized, all other letters lower case;
- second level, numbered 1.1., 1.2., 2.1., etc., first letter capitalized, all other letters lower
case; 
- third level, numbered 1.1.1., 1.1.2., 2.1.1., etc., first letter capitalized, all other letters
lower case; 
- fourth level (if really necessary), not numbered, paragraph indent, runs onto text.
Figures
Research articles may include a figure, which outlines the sequence of recruitment,
measurements, and interventions, indicating the number of subjects at each stage,
etc. Figures of good quality should be submitted online as a separate file. The lettering
should be large enough to permit photographic reduction. Legends should be typed
together on a separate page in the electronic manuscript. If a figure cannot be submitted
online, a hardcopy may be sent to:
Elsevier Ireland Ltd., Brookvale Plaza, East Plaza, Shannon, Co. Clare, Ireland, Fax: +353 61 
709250, PEC@elsevier.com. This address should also be used to submit multimedia files 
Tables 
Tables should be submitted online as a separate file and should bear a short descriptive 
title. Legends for each table should appear on the same page as the table. 
Policy and Ethics 
For work described in your article involving human experimental investigations of any kind, 
must have been carried out in accordance with The Code of Ethics of the Declaration of 
Helsinki; http://www.wma.net/e/policy/b3.htm 
